WO2007066497A1 - Dentifrice composition - Google Patents
Dentifrice composition Download PDFInfo
- Publication number
- WO2007066497A1 WO2007066497A1 PCT/JP2006/323076 JP2006323076W WO2007066497A1 WO 2007066497 A1 WO2007066497 A1 WO 2007066497A1 JP 2006323076 W JP2006323076 W JP 2006323076W WO 2007066497 A1 WO2007066497 A1 WO 2007066497A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mass
- composition
- points
- betaine
- oil
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 75
- 239000000551 dentifrice Substances 0.000 title claims abstract description 37
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims abstract description 35
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims abstract description 35
- 229960003237 betaine Drugs 0.000 claims abstract description 35
- 239000000606 toothpaste Substances 0.000 claims abstract description 34
- 229940034610 toothpaste Drugs 0.000 claims abstract description 31
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 18
- 239000000194 fatty acid Substances 0.000 claims abstract description 18
- 229930195729 fatty acid Natural products 0.000 claims abstract description 18
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims abstract description 17
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims abstract description 17
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 15
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 14
- 239000011230 binding agent Substances 0.000 claims abstract description 14
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 14
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 31
- 210000000214 mouth Anatomy 0.000 abstract description 12
- 241000894006 Bacteria Species 0.000 abstract description 11
- 208000028169 periodontal disease Diseases 0.000 abstract description 5
- 208000002925 dental caries Diseases 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 3
- 239000003082 abrasive agent Substances 0.000 abstract description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 abstract description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 abstract description 2
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 abstract 1
- 238000005187 foaming Methods 0.000 description 32
- -1 Cetyl pyridium Chemical compound 0.000 description 31
- 239000006260 foam Substances 0.000 description 28
- 235000002639 sodium chloride Nutrition 0.000 description 19
- 150000003839 salts Chemical class 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 238000011156 evaluation Methods 0.000 description 16
- 239000003205 fragrance Substances 0.000 description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 11
- 239000003240 coconut oil Substances 0.000 description 11
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 11
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 11
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 11
- 239000004094 surface-active agent Substances 0.000 description 11
- 235000019658 bitter taste Nutrition 0.000 description 10
- 239000013068 control sample Substances 0.000 description 10
- 230000014759 maintenance of location Effects 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 9
- 239000004359 castor oil Substances 0.000 description 9
- 235000019438 castor oil Nutrition 0.000 description 9
- 125000002091 cationic group Chemical group 0.000 description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 7
- 231100000017 mucous membrane irritation Toxicity 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 235000019864 coconut oil Nutrition 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 235000019700 dicalcium phosphate Nutrition 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 5
- 239000003899 bactericide agent Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 239000002563 ionic surfactant Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229940085605 saccharin sodium Drugs 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 3
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical class CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229940070891 pyridium Drugs 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000001542 size-exclusion chromatography Methods 0.000 description 3
- AYGJDUHQRFKLBG-UHFFFAOYSA-M sodium;1,1-dioxo-1,2-benzothiazol-3-olate;dihydrate Chemical compound O.O.[Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 AYGJDUHQRFKLBG-UHFFFAOYSA-M 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- CFAKWWQIUFSQFU-UHFFFAOYSA-N 2-hydroxy-3-methylcyclopent-2-en-1-one Chemical compound CC1=C(O)C(=O)CC1 CFAKWWQIUFSQFU-UHFFFAOYSA-N 0.000 description 2
- 239000000120 Artificial Saliva Substances 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- 235000011203 Origanum Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012897 dilution medium Substances 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000013022 formulation composition Substances 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 150000003016 phosphoric acids Chemical class 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- JHEPBQHNVNUAFL-AATRIKPKSA-N (e)-hex-1-en-1-ol Chemical compound CCCC\C=C\O JHEPBQHNVNUAFL-AATRIKPKSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- MVOSYKNQRRHGKX-UHFFFAOYSA-N 11-Undecanolactone Chemical compound O=C1CCCCCCCCCCO1 MVOSYKNQRRHGKX-UHFFFAOYSA-N 0.000 description 1
- AMSDWLOANMAILF-UHFFFAOYSA-O 2-(1h-imidazol-3-ium-3-yl)ethanol Chemical compound OCC[NH+]1C=CN=C1 AMSDWLOANMAILF-UHFFFAOYSA-O 0.000 description 1
- JLLIMHUDJLLXLO-UHFFFAOYSA-N 2-(methylamino)tetradecanoic acid Chemical compound C(CCCCCCCCCCC)C(C(=O)O)NC JLLIMHUDJLLXLO-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- 239000001837 2-hydroxy-3-methylcyclopent-2-en-1-one Substances 0.000 description 1
- DISYHRKLFBBFAS-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxypropane-1,2-diol Chemical compound CC(C)C1CCC(C)(OCC(O)CO)CC1 DISYHRKLFBBFAS-UHFFFAOYSA-N 0.000 description 1
- IWDFHWZHHOSSGR-UHFFFAOYSA-O 3-ethyl-1h-imidazol-3-ium Chemical compound CCN1C=C[NH+]=C1 IWDFHWZHHOSSGR-UHFFFAOYSA-O 0.000 description 1
- IVFJPARIJHUGPZ-UHFFFAOYSA-N 3-ethyl-2-methylphenol Chemical compound CCC1=CC=CC(O)=C1C IVFJPARIJHUGPZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- TWXUTZNBHUWMKJ-UHFFFAOYSA-N Allyl cyclohexylpropionate Chemical compound C=CCOC(=O)CCC1CCCCC1 TWXUTZNBHUWMKJ-UHFFFAOYSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical class C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000605986 Fusobacterium nucleatum Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 229920001007 Nylon 4 Polymers 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- APTGPWJUOYMUCE-UHFFFAOYSA-N S-Ethyl thioacetate Chemical compound CCSC(C)=O APTGPWJUOYMUCE-UHFFFAOYSA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- RXRBHHUZOXTPSL-UHFFFAOYSA-N [O-]C(C[N+]1(CCO)C=NC=C1)=O Chemical compound [O-]C(C[N+]1(CCO)C=NC=C1)=O RXRBHHUZOXTPSL-UHFFFAOYSA-N 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000010617 anise oil Substances 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 235000019480 chamomile oil Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229940106705 chlorophyll Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000001279 citrus aurantifolia swingle expressed oil Substances 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000001071 citrus reticulata blanco var. mandarin Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- HWDGVJUIHRPKFR-UHFFFAOYSA-I copper;trisodium;18-(2-carboxylatoethyl)-20-(carboxylatomethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18-dihydroporphyrin-21,23-diide-2-carboxylate Chemical compound [Na+].[Na+].[Na+].[Cu+2].N1=C(C(CC([O-])=O)=C2C(C(C)C(C=C3C(=C(C=C)C(=C4)[N-]3)C)=N2)CCC([O-])=O)C(=C([O-])[O-])C(C)=C1C=C1C(CC)=C(C)C4=N1 HWDGVJUIHRPKFR-UHFFFAOYSA-I 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- QYIXCDOBOSTCEI-FBVYSKEZSA-N epidihydrocholesterin Chemical compound C([C@@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-FBVYSKEZSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- OTGHWLKHGCENJV-UHFFFAOYSA-N glycidic acid Chemical compound OC(=O)C1CO1 OTGHWLKHGCENJV-UHFFFAOYSA-N 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
- 229940025294 hemin Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052806 inorganic carbonate Inorganic materials 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 230000009021 linear effect Effects 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical group COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000011644 potassium salts of orthophosphoric acid Substances 0.000 description 1
- 235000019858 potassium salts of orthophosphoric acid Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229940079841 sodium copper chlorophyllin Drugs 0.000 description 1
- 235000013758 sodium copper chlorophyllin Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- FVRNDBHWWSPNOM-UHFFFAOYSA-L strontium fluoride Chemical compound [F-].[F-].[Sr+2] FVRNDBHWWSPNOM-UHFFFAOYSA-L 0.000 description 1
- 229910001637 strontium fluoride Inorganic materials 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/54—Polymers characterized by specific structures/properties
- A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
- A61K2800/5422—Polymers characterized by specific structures/properties characterized by the charge nonionic
Definitions
- 000 it is possible to maintain stable bactericidal activity of zinc without impairing its foaming ability and use, and it has an excellent bactericidal action against oral bacteria, and gingivitis due to oral bacteria, alveolar leakage, etc. It is suitable for the prevention and treatment of dental caries, etc. and is related to toothpaste.
- 002, 2 It is thought that it is due to various bacteria in the oral plaque of the oral cavity, and in particular, the eclipse is a series of stups, castas (S as), etc., and deviations of NAS (P as), etc. It is an infectious disease caused by bacteria, mainly anaerobic glucose, and oral bacteria such as the potassium quatum (cea) are involved in the cause of halitosis. Therefore, it is said that it is effective to keep the bacteria in the plant and oral cavity at a low level as an effective means for preventing and improving the oral cavity disease.
- Oral composition containing specific pooxin hydrate (), oral cavity containing dipodium oxypoxitone (2), oral composition containing cation and water-soluble acid salt (4) and an oral composition containing a cation and a binding agent (8) have been proposed, but the deviation has not been able to give sufficient standing.
- the oral composition (5) or a mixture of an axium compound with a fixed proportion of cuxtons and non-ions was used.
- An oral composition containing cations and pooxin akites as effervescent has been proposed (6), but these techniques have not been proposed for specific and amphoteric ones, and they have not been proposed for the onion of launatome and the like. Compared with the case of blending, it did not provide sufficient standing.
- the purpose is to provide a toothpaste that has various uses.
- At least one kind selected from akimethyanotine, adoptiteine, and 2 achicabometiumine. 6 to 3 should be compounded, and the composition amount should be 5 or less. In addition, it has a composition that does not substantially contain Aon, and has good foaming ability and good use.
- composition amount is 5
- the above-mentioned 1 is characterized in that the content is 6-6 to 2.5, and the above-mentioned 1 is further prepared as polishing 7-6, 5-5, ...- 5.
- Zinc Zinc, () ces, (C) Achimethyanotine, Adoptiteine, 2 Achymethine Tyne, and at least two amphoteric amphiphiles, and more preferably () Pupimetis It does not contain a and substantially contains a.
- the amount of () used in 001 Ming is thione, and it is available from Wako, Kanto Gaku Kogyo, Tokyo, etc. , More preferable for sterilization and use with respect to the composition amount is ... to 5, and more preferable is to .... ⁇ In the case of ⁇ , it is not sufficient, and ⁇ In the case of more than 5, there are cases in which unique feelings occur and it is not preferable in terms of feeling.
- the amount of 015 () minutes is AEON, and those sold by Daise Industries Co., Ltd. can be used.
- the ratio of standing to the composition amount is ⁇ 2 ⁇ ⁇ 5, and more preferable is ⁇ 4 ⁇ . ⁇ In the case of 2, the standing is not sufficient, and ⁇ In the case of exceeding 5, there is a possibility that the situation may occur.
- the amount of hidden protein is not particularly limited, but the composition is maintained. It has a weight average molecular weight of ⁇ 30,000, and more preferably 50,000 ⁇ 20,000.
- an average molecule of hydrates, a size cutlery (SC) was used, and a pondoxide was used to form the curve, and the molecule was measured as a pohnoxide calculation.
- amphoteric properties selected from umtain.
- Aki it is preferable to have a prime number of 8 to 2 and more preferable to be 8 in terms of lack of standing and bitterness even when there is a gap.
- Akimethanoine has the product name 3 Nikko
- the yaf fat ad-uptaine solution sold by e ssa under the trade name GO ea C or GO ea 5 GO ea Z is used.
- 2 Akiba methium tines are sold by Lion Corporation under the trade name Naji 4
- Cabomethium tin sodium solution is used, but the deviation is not limited to the above.
- bitterness is the composition amount, which is more preferably ⁇ 5 to 2 ⁇ , and the more preferable amount is to ⁇ 5. ⁇ Five However, if it exceeds 2, the bitterness may occur.
- Pupimetis as ().
- the Pupimetis used in Ming is the same ion as Hidase, and the products sold under the product name of Methoz by Shin-Etsu Chemical Co., Ltd. can be used.
- (2 C) has a viscosity of 2 to 35 Pa ⁇ s when measured with a single cylindrical profilometer (Type 2 manufactured by Tokimec Co., Ltd., Ta o, 2 or 4 is used, rotation, measurement time 4).
- 2 to OO Pa ⁇ s is preferable from the viewpoint of sex, and when 002 PP is compounded, it is preferable from the viewpoint of sex with respect to the composition amount ⁇ 5 to 2 and more preferably.
- ⁇ ⁇ ⁇ Sufficient performance may not be achieved with 5, and if it exceeds 2, there is a risk of roughening at low temperatures due to insoluble polypropylene.
- the amount of () of Pupimetis should be 6 to 2.5, especially 2 to 2 when the amount of () is It is more preferable to blend it as much as possible. ⁇ 6 may not be able to give sufficient amount, and if it exceeds 2.5, the fineness of the foam may be lost and further may occur.
- the water content is 5 below, preferably 5 to 4. If the amount exceeds 5, the initial and time characteristics will decrease and further will occur. 5 If not satisfied, insoluble and popimethses may be produced.
- Sweeteners, preservatives, active ingredients, dyes, and flavors can be added, and these ingredients can be mixed with water.
- Um magnesium carbonate, 3 magnesium, olite, calcium, 3 ammonium, idotite, ottoite, umuatitite, 3 magnesium, 4 magnesium, 8 magnesium, synthetic resin abrasive And the like can be blended in combination of two or more.
- an onthione viscosity that reduces the sex of zinc can be blended, and other onions include, for example, methices, hydrmethices, and hydropathy. Etc. You can Examples of the thione viscosity include cations and the like. These can be blended alone or in combination of two or more, and the content is usually .about.5 with respect to the composition amount. For 003, the composition of Aon
- amphoteric sex other than (C) examples include, for example, amethyst such as glutam and styidiagno.
- amethyst such as glutam and styidiagno.
- poukitin which has 5 to 8 tin atoms, and 2 to 25, which has 8 tin atoms
- pookitin aki which has 2 to 25 prime atoms
- Steroids chitostea, stearin noxelide, pookitinson norato, pookitinsonnosteato, rooigitanoad, etc., and pookitin pookipupipi Ring, langse, etc. Two or more of these may be combined and compounded, and the content is usually from .about.5 to the composition amount.
- saccharin sodium Aslatem, steviside, steviakis, rat quinacaldehyde, neocan, ratin, etc. , Sodium benzoate and the like. It should be noted that these components can be generally used as long as they do not interfere with the results of the present invention.
- active ingredients other than 003dium examples include sodium, sodium, potassium, sodium, sodium, etc., potassium orthoses, soluble sodium, trasm, and the like.
- Tongue products such as botanicals, quincines, guan, gutin, gutin, quinatoum, qui, guess, etc., gutin products, ammonium lactate, strontium, calcium, bebe Amine, hydramic acid and its conductors, sodium, olite, methoxine, anhydrous in-polymer, podone,
- Examples thereof include extracts of stainless steel, sodium chloride, sodium chloride, stainless steel, Toka, Ku, Toukisu, Okisu, Tsu, clove, zu, n, na and the like. It can be effective, but it is usually .about.5 with respect to the composition amount.
- Pent, sparet ass, mosquito, winter, kar, ku, thyme, seg, ng, sword, sack, force, unders, dan, lime, vendor, zus, force , Kyaraui, Joram, Bay, Ngrass, Oganum, India ,,,,,,,,,,,,,,,,, and (,,,,,,,,,,,,,,,,,,,,,,,,, (dose), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), (), [] , Menthone, Menchiate, Ramentan 3 Cabo, Nene, Octadehyde, Tora, Vietnamese, Viatte, Asadehyde, Cheateto, Chichito, Akxamppionet, Methians Rat, Methyltide, N,
- Nana, Inup, Gup, N, Ta, Ku, Tox, Topicatu and other mixed flavors, and toothpaste materials can be used, and are not limited to the amount used.
- the amount of the fragrance is not particularly limited, it is preferably used during the preparation of the above-mentioned.
- composition is the mass and the composition is the mass.
- a test containing the ingredients shown in 2 was prepared by a conventional method, and evaluated by the sterilization test, test, use (standing in, no bitterness, mucous membrane), and the following method. The results are shown in Table 2. In addition, to make these,
- Dye (Co., Ltd.), Hydses (Daisei Kogyo Co., Ltd., C 82 Equivalent molecule 3), Laumethia Notine (Kez Co., Ltd. O 3, Yaakikabo Methium Tyne Natoum (Lion ( Naji C 4) and yaf fat adoptaine (esa ⁇ GO ea C) were used.For the amount, launatoum, toothpaste hydrogen ⁇ 2, anhydrous silica, titanium, potting were used. 4, methysathonium, carrageenan, pooxin (2) syrup, saccharinium, 85 gs, refined , Nononatum used a medicine.
- a test containing the ingredients shown in 3 was prepared by a conventional method, and the sterilization test, test, and use (standing in, no bitterness, mucous membrane, foam fineness,
- Umtyne (Naio C 4 manufactured by Rio Co., Ltd.) and yaf fat adupitaine (essa ⁇ GO e a C) were used.
- toothpaste hydrogen ⁇ 2 anhydrous silica, titanium, potting
- 3 to 3 were prepared, and using the subject's name, the answers were obtained on the 3rd floor: toothpaste on the market with 3 runs, bitterness felt during use, with moderate, with. In this answer, 3 was used, 2 was slightly used, and 2 was used, and the use was evaluated below the average score of the names.
- Thread height is ⁇ Oc
- the thread height is Oc 2 Oc
- Thread height is 2 Oc 3 Oc
- the product had the sterilization derived from zinc, did not impair the foaming ability and use, had no mucous membrane, and had a high degree of fineness of foam.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
A dentifrice composition containing (A) cetylpyridinium chloride, (B) hydroxyethylcellulose, and (C) an amphoteric surfactant selected from alkyldimethylaminoacetate betaine, fatty acid amide propylbetaine and 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolium betaine in which the mass ratio of (C)/(B) is 0.06 to 3, the water content is 50% by mass or less and an anionic surfactant is not practically contained. The dentifrice composition further containing (D) hydroxypropylmethylcellulose in which the mass ratio of (D)/(B) is 0.06 to 2.5, and the dentifrice composition further contained 7 to 60% by mass of an abrasive agent, 5 to 50% by mass of a thickening agent, and 0.1 to 5% by mass of a binder which is prepared as a toothpaste composition. The dentifrice composition is excellent in a bactericidal action against bacteria in the oral cavity, good in usability and useful for the prevention or treatment of a periodontal disease or dental caries.
Description
明 細 書 Specification
歯磨組成物 toothpaste composition
技術分野 Technical field
[0001] 本発明は、発泡性能や味、使用感を損なわずに塩ィ匕セチルピリジニゥムの高い殺 菌活性を維持して安定配合することができ、口腔内細菌に対して優れた殺菌作用を 有し、 口腔内細菌による歯肉炎、歯槽膿漏などの歯周病やう蝕などの予防、治療に 好適で、かつ使用感の良好な歯磨組成物に関する。 [0001] The present invention enables stable blending of cetylpyridinium salt while maintaining its high bactericidal activity without impairing foaming performance, taste, or feeling of use, and is effective against oral bacteria. The present invention relates to a toothpaste composition that has a bactericidal effect, is suitable for the prevention and treatment of periodontal diseases such as gingivitis and alveolar pyorrhea caused by oral bacteria, and caries, and is comfortable to use.
背景技術 Background technology
[0002] う蝕、歯周病の 2大口腔疾患の原因は、口腔内プラーク中の各種細菌によるもので あると考えられ、特に、う蝕は、ストレプトコッカス ミュータンス(S. mutans)等の連鎖 球菌、歯周病はボルフイロモナス ジンジバリス (P. gingivalis)等の偏性嫌気性ダラ ム陰性桿菌を主とした細菌による感染症であり、また、口臭の原因としてはフゾバクテ リウム ヌクレアタム(F. nucleatum)等の口腔内細菌が関与している。従って、口腔 内疾患の予防、改善に有効な手段として、プラークコントロール、即ち、口腔内の病 原性細菌数を低レベルに保つことが有用であることが言われている。 [0002] The two major oral diseases, caries and periodontal disease, are thought to be caused by various bacteria in oral plaque. Cocci and periodontal diseases are infections caused by bacteria, mainly obligate anaerobic Durum-negative rods such as P. gingivalis, and causes of bad breath include F. nucleatum and other bacteria. oral bacteria are involved. Therefore, it is said that plaque control, that is, keeping the number of pathogenic bacteria in the oral cavity at a low level, is useful as an effective means for preventing and improving oral diseases.
[0003] 口腔内の病原性細菌数を低下させる手段としては、従来から優れた口腔組織吸着 性を有し、殺菌力及びプラーク形成抑制作用の高いカチオン性殺菌剤である塩ィ匕セ チルピリジ-ゥムを歯磨組成物に配合することが知られている。また、歯磨剤等の口 腔用組成物では必須である香料などの油性成分の可溶ィ匕や、十分な泡立ちを付与 するためにラウリル硫酸ナトリウム等のァ-オン性界面活性剤を用いることも知られて いる。 [0003] As a means to reduce the number of pathogenic bacteria in the oral cavity, salt pyridine, a cationic bactericidal agent that has excellent oral tissue adsorption properties and has high bactericidal and plaque formation inhibiting effects, has been used. It is known that dentifrice compositions include dentifrice compositions. In addition, in oral compositions such as dentifrices, it is necessary to dissolve oily ingredients such as fragrances, which are essential, and to provide sufficient foaming, anionic surfactants such as sodium lauryl sulfate are used. is also known.
[0004] し力しながら、上記塩ィ匕セチルピリジニゥムをァ二オン性界面活性剤と併用した場 合、それが有する電荷ゆえに、ァ-オン性界面活性剤と静電的コンプレックスを形成 して殺菌活性が低下するという課題があった。一方で塩ィ匕セチルピリジ-ゥムの殺菌 活性を維持するためにァ-オン性界面活性剤を含有させな ヽ場合は、油溶成分の 可溶化や、十分な泡立ちの付与ができな 、と 、う課題があった。 [0004] When the above cetylpyridinium salt is used in combination with an anionic surfactant, it forms an electrostatic complex with the anionic surfactant due to the charge it has. There was a problem that the bactericidal activity decreased due to the formation of microorganisms. On the other hand, if an ionic surfactant is not included in order to maintain the bactericidal activity of cetylpyridium salt, it may not be possible to solubilize oil-soluble components or provide sufficient foaming. There was an issue.
[0005] 塩ィ匕セチルピリジ-ゥムの殺菌活性を維持するための手段としては、塩化セチルビ
リジ-ゥムと特定のポリオキシエチレン硬化ヒマシ油とを配合した口腔用液体製剤(特 許文献 1参照)や、塩ィ匕セチルピリジ-ゥムとポリオキシエチレンポリオキシプロピレン グリコールとを配合した口腔用液体製剤 (特許文献 2参照)、カチオン性殺菌剤と水 溶性無機炭酸塩を配合した口腔用組成物 (特許文献 4参照)や、カチオン性殺菌剤 と結晶セルロースを含有させた口腔用組成物 (特許文献 8参照)が提案されて ヽるが 、いずれも十分な泡立ちが付与できていな力つた。 [0005] As a means to maintain the bactericidal activity of cetylpyridium chloride, Oral liquid preparations containing Cetyl pyridium and specific polyoxyethylene hydrogenated castor oil (see Patent Document 1), and oral liquid preparations containing Cetyl pyridium salt and polyoxyethylene polyoxypropylene glycol. (see Patent Document 2), oral compositions containing a cationic bactericide and a water-soluble inorganic carbonate (see Patent Document 4), and oral compositions containing a cationic bactericide and crystalline cellulose. (See Patent Document 8) have been proposed, but none of them have been able to provide sufficient foaming.
[0006] また、塩化セチルピリジ-ゥムの殺菌活性の維持と、泡立ちとの両立を図った手段 として、アルキル四級アンモ-ゥム化合物に対し、一定比率のシクロデキストリン類と 非イオン性発泡剤とを添加した口腔用組成物 (特許文献 5参照)や、カチオン性殺菌 剤と発泡剤としてポリオキシエチレンアルキルエーテルを配合した口腔用組成物(特 許文献 6参照)が提案されている力 これらの技術では、特定の粘結剤と両性界面活 性剤については提案されておらず、ラウリル硫酸ナトリウム等のァ-オン性界面活性 剤を配合した場合と比較すると十分な泡立ちの付与にはならなかった。 [0006] In addition, as a means to maintain both the bactericidal activity of cetylpyridium chloride and foaming, a certain ratio of cyclodextrins and a nonionic foaming agent to an alkyl quaternary ammonium compound was added. Oral compositions containing a cationic bactericide and polyoxyethylene alkyl ether as a foaming agent (see Patent Document 6) have been proposed. In this technology, specific binders and amphoteric surfactants are not proposed, and compared to the case where an aionic surfactant such as sodium lauryl sulfate is blended, sufficient foaming cannot be imparted. There wasn't.
[0007] 一方、オルガノシリコン型第四級アンモ-ゥムを固定ィ匕した水不溶性固体を有効成 分とし、ベタイン型界面活性剤、非イオン性及びカチオン性粘結剤を配合することに より、オルガノシリコン型固定ィ匕殺菌剤を安定ィ匕した口腔用組成物 (特許文献 3、 7参 照)において塩ィ匕セチルピリジ-ゥムを配合することが提案されている。しかし、これら 技術においても、塩ィ匕セチルピリジ-ゥムのような水溶性殺菌剤の安定ィ匕は図られて いない。また、ァ-オン性界面活性剤と比較して十分な泡立ちを付与するためにベタ イン型界面活性剤を配合したことによって、口腔粘膜への刺激や苦味、製剤としての 曳糸性が生じ、十分な殺菌力と良好な使用感との両者を満足するものは得られてい なかった。 [0007] On the other hand, by using a water-insoluble solid in which organosilicon type quaternary ammonium is fixed as an active ingredient, and adding a betaine type surfactant and a nonionic and cationic binder, It has been proposed to incorporate cetylpyridium salt into oral compositions stably containing organosilicon-type fixed fungicides (see Patent Documents 3 and 7). However, even with these technologies, stabilization of water-soluble fungicides such as cetylpyridium salt has not been attempted. In addition, the inclusion of a betaine type surfactant to provide sufficient foaming compared to anionic surfactants causes irritation to the oral mucosa, bitterness, and stringiness as a formulation. It has not been possible to obtain a product that satisfies both sufficient sterilizing power and a good feeling of use.
[0008] 特許文献 1 :特開平 4 173728号公報 [0008] Patent document 1: Japanese Patent Application Laid-open No. 4 173728
特許文献 2:特開平 4 - 198120号公報 Patent document 2: Japanese Patent Application Laid-Open No. 4-198120
特許文献 3:特開平 6 - 24947号公報 Patent Document 3: Japanese Unexamined Patent Publication No. 6-24947
特許文献 4:特開平 8— 245353号公報 Patent document 4: Japanese Patent Application Laid-Open No. 8-245353
特許文献 5:特開平 8 - 259428号公報 Patent document 5: Japanese Patent Application Laid-Open No. 8-259428
特許文献 6:特開平 10 - 175832号公報
特許文献 7:特許第 3006960号公報 Patent document 6: Japanese Patent Application Laid-Open No. 10-175832 Patent document 7: Patent No. 3006960
特許文献 8 :特開 2002— 179541号公報 Patent document 8: Japanese Patent Application Publication No. 2002-179541
発明の開示 Disclosure of invention
発明が解決しょうとする課題 Problems that the invention seeks to solve
[0009] 本発明は、上記事情に鑑みなされたもので、発泡性能や味、使用感を損なわずに 塩ィ匕セチルピリジ-ゥムの高い殺菌活性を維持して安定配合することができ、口腔内 細菌に対して優れた殺菌作用を有するとともに、良好な使用感を有する歯磨組成物 を提供することを目的とする。 [0009] The present invention was developed in view of the above circumstances, and it is possible to maintain the high bactericidal activity of cetylpyridium salt without impairing the foaming performance, taste, or feeling of use, and to stably blend it into the oral cavity. An object of the present invention is to provide a toothpaste composition that has an excellent bactericidal effect against bacteria and has a good feeling of use.
課題を解決するための手段 Means to solve problems
[0010] 本発明者は、上記目的を達成するため鋭意研究を重ねた結果、ァ-オン性界面活 性剤の発泡性能に代替し得る界面活性剤を探求するのみならずメレンゲを作る際の メカニズムに着目し、塩ィ匕セチルピリジ-ゥムと静電的コンプレックスを形成しない非 イオン性粘結剤のヒドロキシェチルセルロースに高い泡安定ィ匕作用があることを見出 し、更に上記ヒドロキシェチルセルロースに対し、香料等の油溶成分の可溶化と起泡 のためにアルキルジメチルァミノ酢酸べタイン、脂肪酸アミドプロピルべタイン、 2—ァ ノレキノレ -N-カノレボキシメチノレ -N-ヒドロキシェチルイミダゾリ-ゥムベタインから 選ばれる少なくとも一種の両性界面活性剤を質量比で 0. 06〜3の割合で配合し、か つ組成物中の水分含量を 50質量%以下とすることにより、ァ-オン性界面活性剤を 実質的に含有しない組成で、発泡性能や味、使用感が良好で、かつ塩化セチルピリ ジニゥム由来の十分な殺菌効果を発揮できる歯磨組成物が得られることを見出し、本 発明を完成するに至った。 [0010] As a result of extensive research in order to achieve the above object, the present inventor has not only searched for a surfactant that can replace the foaming performance of anionic surfactants, but also developed a surfactant that can be used in making meringue. Focusing on the mechanism, they discovered that hydroxyethylcellulose, a nonionic binder that does not form an electrostatic complex with cetylpyridium salt, has a high foam stabilizing effect. For chill cellulose, alkyldimethylaminoacetic acid betaine, fatty acid amidopropyl betaine, 2-alkyldimethylaminoacetic acid betaine, 2-alkyl-N-canoleboxymethynole-N-hydroxy are used to solubilize and foam oil-soluble ingredients such as fragrances. By blending at least one amphoteric surfactant selected from ethyl imidazolium betaine in a mass ratio of 0.06 to 3, and by controlling the water content in the composition to 50% by mass or less, -We have discovered that it is possible to obtain a toothpaste composition that has a composition that does not substantially contain onionic surfactants, has good foaming performance, taste, and feeling of use, and can also exhibit sufficient bactericidal effects derived from cetylpyridinium chloride. The invention was completed.
[0011] 従って、本発明は、〔I〕(A)塩化セチルピリジ-ゥム、(B)ヒドロキシェチルセルロー ス、(C)アルキルジメチルァミノ酢酸べタイン、脂肪酸アミドプロピルべタイン、 2—ァ ノレキノレ N カノレボキシメチノレ N ヒドロキシェチルイミダゾリ-ゥムベタインから 選ばれる少なくとも 1種の両性界面活性剤を含有し、前記 (B)成分に対する(C)成分 の配合割合が質量比で 0. 06〜3であり、かつ組成物中の水分含量が 50質量%以 下であり、ァ-オン性界面活性剤を実質的に含有しないことを特徴とする歯磨組成 物、〔II〕更に、(D)ヒドロキシプロピルメチルセルロースを含有し、(B)成分に対する(
D)成分の配合割合が質量比で 0. 06-2. 5であることを特徴とする上記〔I〕の歯磨 組成物、及び〔III〕更に、研磨剤を 7〜60質量%、粘稠剤を 5〜50質量%、及び粘 結剤を 0. 1〜5質量%配合し、練歯磨組成物として調製された上記〔I〕又は〔II〕の歯 磨組成物を提供する。 [0011] Therefore, the present invention provides [I] (A) cetylpyridium chloride, (B) hydroxyethylcellulose, (C) alkyl dimethylaminoacetic acid betaine, fatty acid amidopropyl betaine, 2-a Contains at least one kind of amphoteric surfactant selected from the group consisting of N, N, and Hydroxyethyl imidazolium betaine, and the blending ratio of component (C) to component (B) is 0.06 by mass. - 3, the water content in the composition is 50% by mass or less, and the dentifrice composition is characterized in that it does not substantially contain an ionic surfactant, [II] furthermore, (D ) Contains hydroxypropyl methylcellulose, and contains (B) component ( D) The toothpaste composition of [I] above, characterized in that the blending ratio of the components is 0.06-2.5 in terms of mass ratio, and [III] the toothpaste composition further contains an abrasive of 7 to 60% by mass and a viscous The dentifrice composition of [I] or [II] above is prepared as a toothpaste composition by blending 5 to 50% by mass of the agent and 0.1 to 5% by mass of the binder.
発明の効果 Effect of the invention
[0012] 本発明の歯磨組成物は、優れた発泡性能や味、使用感を有し、かつ、塩化セチル ピリジ-ゥム由来の高い殺菌活性を維持して安定配合することができ、口腔内細菌に 対して優れた殺菌作用を有すると共に、良好な使用感を有するもので、口腔内細菌 による歯肉炎、歯槽膿漏などの歯周病やう蝕などの予防、治療に有用である。 [0012] The dentifrice composition of the present invention has excellent foaming performance, taste, and feeling of use, and can be stably blended while maintaining high bactericidal activity derived from cetyl pyridium chloride. It has an excellent bactericidal effect against bacteria and has a pleasant feeling of use, making it useful for the prevention and treatment of periodontal diseases such as gingivitis and pyorrhea caused by oral bacteria, and dental caries.
発明を実施するための最良の形態 BEST MODE FOR CARRYING OUT THE INVENTION
[0013] 以下、本発明につき更に詳細に説明すると、本発明の歯磨組成物は、(A)塩ィ匕セ チルピリジ-ゥム、 (B)ヒドロキシェチルセルロース、 (C)アルキルジメチルァミノ酢酸 ベタイン、脂肪酸アミドプロピルべタイン、 2—アルキル—N—カルボキシメチルー N —ヒドロキシェチルイミダゾリニゥムベタインカ 選ばれる少なくとも 1種の両性界面活 性剤、更に好ましくは(D)ヒドロキシプロピルメチルセルロースを含有し、ァ-オン性 界面活性剤を実質的に含有しないものである。 [0013] To explain the present invention in more detail below, the dentifrice composition of the present invention includes (A) salt acylpyridium, (B) hydroxyethylcellulose, and (C) alkyldimethylaminoacetic acid. Betaine, fatty acid amidopropyl betaine, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, at least one selected amphoteric surfactant, more preferably (D) hydroxypropyl methylcellulose. It contains substantially no aionic surfactant.
[0014] 本発明で用いる (A)成分の塩ィ匕セチルピリジ-ゥムはカチオン性殺菌剤であり、和 光純薬工業 (株)、関東ィ匕学工業 (株)、東京化成工業 (株)などの試薬メーカーから 入手可能である。配合量は、組成物全量に対して殺菌力や使用感の点より好ましく は 0. 001-0. 5質量%、より好ましくは 0. 01-0. 1質量%である。配合量が 0. 00 1質量%未満では十分な殺菌力が発揮されず、 0. 5質量%を超えると独特の苦みが 生じ使用感の面力 好ましくない場合がある。 [0014] Component (A) used in the present invention, cetylpyridium salt, is a cationic bactericide and is manufactured by Wako Pure Chemical Industries, Ltd., Kanto Igaku Kogyo Co., Ltd., and Tokyo Kasei Kogyo Co., Ltd. It is available from reagent manufacturers such as The blending amount is preferably 0.001-0.5% by mass, more preferably 0.01-0.1% by mass based on the total amount of the composition in terms of bactericidal activity and usability. If the blending amount is less than 0.001% by mass, sufficient bactericidal activity will not be exhibited, and if it exceeds 0.5% by mass, a unique bitter taste may occur and the texture may be unfavorable.
[0015] (B)成分のヒドロキシェチルセルロースは非イオン性粘結剤であり、ダイセル化学ェ 業 (株)から販売されているものなどを使用できる。配合量は、組成物全量に対して泡 立ちゃ曳糸性の点より好ましくは 0. 2〜1. 5質量0 /0、より好ましくは 0. 4〜1. 0質量 %である。配合量が 0. 2質量%未満では泡立ちが十分ではなぐまた、 1. 5質量% を超えると曳糸性が生じるおそれがある。 [0015] Hydroxyethyl cellulose, component (B), is a nonionic binder, and those sold by Daicel Chemical Industries, Ltd. can be used. The blending amount is preferably 0.2 to 1.5% by weight, more preferably 0.4 to 1.0 % by weight, based on the total amount of the composition in terms of foaming and stringability. If the amount is less than 0.2% by mass, foaming will not be sufficient, and if it exceeds 1.5% by mass, stringiness may occur.
[0016] また、ヒドロキシェチルセルロースの分子量は特に制限されな 、が、組成物に保型
性を持たせる点より重量平均分子量 10万〜 300万が好ましぐ更に好ましくは 50万 〜200万である。ここで、ヒドロキシェチルセルロースの重量平均分子量は、サイズ排 除クロマトグラフィー(SEC)を用い、較正曲線の作成には短分散ポリエチレンォキサ イドを使用し、ポリエチレンオキサイド換算として分子量を測定した。具体的には、 0. 20mol/L酢酸リチウム緩衝液 (pH4. 8)及び 0. 25質量0 /0ランダムメチル j8—シク ロデキストリン (RAMEB— CD)移動相中で、カラム及び屈折率検出器の両方をサー モスタツトで 40°Cに調温して SEC測定を行い、 1組の TSK—Gelカラム(3 GMPW XL Linears + G3000P WXL in series)によって、流量 1. OmL/分におい て、ポリマーをクロマトグラフィーにかけた。 0. 20質量0 /0のサンプル濃度を、 200 μ L· の注入容量において使用し、測定した。 [0016] In addition, the molecular weight of hydroxyethyl cellulose is not particularly limited, but the composition retains its shape. The weight average molecular weight is preferably 100,000 to 3,000,000, more preferably 500,000 to 2,000,000 from the viewpoint of imparting properties. Here, the weight average molecular weight of hydroxyethylcellulose was measured using size exclusion chromatography (SEC), short dispersion polyethylene oxide was used to create a calibration curve, and the molecular weight was measured in terms of polyethylene oxide. Specifically, the column and refractive index detector were incubated in a 0.20 mol/L lithium acetate buffer (pH 4.8) and a 0.25 mass 0/0 random methyl j8-cyclodextrin (RAMEB-CD) mobile phase. Both were thermostatted at 40°C for SEC measurements, and the polymer was collected using a pair of TSK—Gel columns (3 GMPW XL Linears + G3000P WXL in series) at a flow rate of 1.0 mL/min. Chromatographed. A sample concentration of 0.20 mass 0/0 was used and measured in an injection volume of 200 μL·.
[0017] また、本発明の歯磨組成物は、(C)成分としてアルキルジメチルァミノ酢酸べタイン 、脂肪酸アミドプロピルべタイン、 2—アルキル—N—カルボキシメチルー N ヒドロキ シェチルイミダゾリ-ゥムベタインカも選ばれる少なくとも 1種の両性界面活性剤を含 有する。 [0017] The toothpaste composition of the present invention also contains alkyldimethylaminoacetic acid betaine, fatty acid amidopropyl betaine, and 2-alkyl-N-carboxymethyl-N-hydroxycetylimidazolium betaine as the component (C). Contains at least one selected amphoteric surfactant.
[0018] 上記両性界面活性剤のアルキル鎖長としては、いずれの場合も泡立ちや苦味のな さの点から、好ましくは炭素数 8〜20、より好ましくは 10〜18のものである。アルキル ジメチルァミノ酢酸べタインの例としては、商品名 NIKKOL AM— 301として日光 ケミカルズ (株)より販売されて!ヽるラウリルジメチルァミノ酢酸べタイン水溶液等が用 いられる。脂肪酸アミドプロピルべタインの例としては、商品名 TEGO BetainCKや TEGO BetainF50、 TEGO BetainZFとして Degussa.社より販売されているャ シ油脂肪酸アミドプロピルべタイン水溶液等が用いられる。また、 2—アルキル N— カルボキシメチルー N ヒドロキシェチルイミダゾリ-ゥムベタインとしては、商品名工 ナジコール C - 40Hとしてライオン (株)より販売されて!、る 2 ヤシ油アルキル N -カノレボキシメチノレ -N -ヒドロキシェチルイミダゾリ-ゥムベタインナトリゥム水溶液 等が用いられる力 いずれの場合も上記に限ったものではない。 [0018] The alkyl chain length of the amphoteric surfactant is preferably 8 to 20 carbon atoms, more preferably 10 to 18 carbon atoms, from the viewpoint of no foaming or bitter taste. As an example of alkyl dimethylaminoacetic acid betaine, an aqueous lauryl dimethylaminoacetic acid betaine solution sold by Nikko Chemicals Co., Ltd. under the trade name NIKKOL AM-301 can be used. Examples of fatty acid amidopropyl betaine include aqueous solutions of coconut oil fatty acid amidopropyl betaine sold by Degussa under the trade names TEGO BetainCK, TEGO BetainF50, and TEGO BetainZF. In addition, 2-alkyl N-carboxymethyl-N-hydroxyethylimidazolium betaine is sold by Lion Co., Ltd. under the trade name Nadicol C-40H. -N-Hydroxyethylimidazolium betaine sodium aqueous solution, etc. are used. In any case, it is not limited to the above.
[0019] これらの両性界面活性剤は、 1種を単独で用いても 2種以上を併用しても良い。ま た、その合計配合量は、起泡量や苦味の点より純分換算として組成物全量に対して 、好ましく ίま 0. 05〜2. 0質量0 /0、より好ましく ίま 0. 1〜1. 5質量0 /0である。 0. 05質
量%未満では十分な起泡量は得られず、また 2. 0質量%を超えると苦味が生じるお それがある。 [0019] These amphoteric surfactants may be used alone or in combination of two or more. In addition, from the viewpoint of foaming amount and bitterness, the total amount of the composition is preferably 0.05 to 2.0 mass 0/0 , more preferably 0.1 based on the total amount of the composition in terms of pure content. ~1.5 mass 0/0 . 0.05 quality If it is less than 2.0% by mass, sufficient foaming volume cannot be obtained, and if it exceeds 2.0% by mass, bitterness may occur.
[0020] 本発明では、発泡性能や味、使用感を損なわずに塩ィ匕セチルピリジ-ゥムを活性 配合するために、(B)成分のヒドロキシェチルセルロースに対して上記(C)成分の両 性界面活性剤を質量比で 0. 06〜3、好ましくは泡立ちや使用感の点より 0. 1〜2の 割合で配合することが必要である。配合比が 0. 06未満では十分な泡立ちを付与で きず、 3を超えると曳糸性及び苦味が生じるため使用感が悪くなる。 [0020] In the present invention, in order to actively blend cetylpyridium salt without impairing foaming performance, taste, and feeling of use, the above component (C) is added to the hydroxyethylcellulose component (B). It is necessary to blend the amphoteric surfactant in a mass ratio of 0.06 to 3, preferably 0.1 to 2 from the viewpoint of foaming and feel on use. When the blending ratio is less than 0.06, sufficient foaming cannot be imparted, and when it exceeds 3, stringiness and bitterness occur, resulting in a poor feeling of use.
[0021] 更に本発明では、泡保持性を高め、泡にきめ細かさを与えるために、(D)成分とし てヒドロキシプロピルメチルセルロースを配合することができる。本発明で用いるヒドロ キシプロピルメチルセルロースは、ヒドロキシェチルセルロースと同じく非イオン性粘 結剤であり、信越ィ匕学工業 (株)からメトローズの商品名で販売されているものなどを 使用することができる。 [0021] Furthermore, in the present invention, hydroxypropyl methylcellulose can be blended as component (D) in order to enhance foam retention and give fineness to the foam. The hydroxypropyl methyl cellulose used in the present invention is a nonionic binder like hydroxyethyl cellulose, and the one sold by Shin-Etsu Igaku Kogyo Co., Ltd. under the trade name Metrose can be used. can.
[0022] ヒドロキシプロピルセルロースの粘度は特に制限されな!、が、 2質量0 /0水溶液の粘 度(20°C)が単一円筒形回転粘度計( (株)トキメック製 TVB— 20L型、ローター No. L、 M2又は M4を使用、回転数 60rpm、測定時間 4分)で測定した時の粘度が、 2〜 35000mPa' s、特に 20〜: LO, OOOmPa' sであることが、泡保持性の点から好ましい [0022] The viscosity of hydroxypropylcellulose is not particularly limited! However, the viscosity of a 2 mass 0/0 aqueous solution ( 20 °C) can be measured using a single cylindrical rotational viscometer (TVB-20L model manufactured by Tokimec Co., Ltd.). To ensure foam retention, the viscosity when measured using rotor No. L, M2 or M4 (rotation speed 60 rpm, measurement time 4 minutes) is between 2 and 35000 mPa's, especially between 20 and LO, OOOmPa's. preferred in terms of gender
[0023] ヒドロキシプロピルセルロースを配合する場合、その配合量は、組成物全量に対し て泡保持性の点から好ましくは 0. 05〜2質量%、より好ましくは 0. 1〜1. 0質量% である。 0. 05質量%未満では十分な泡保持性が発揮されない場合があり、また、 2 質量%を超えると不溶なヒドロキシプロピルメチルセルロースにより低温での肌荒れ が起こるおそれがある。 [0023] When hydroxypropylcellulose is blended, the blending amount is preferably 0.05 to 2% by mass, more preferably 0.1 to 1.0% by mass based on the total amount of the composition from the viewpoint of foam retention. It is. If it is less than 0.05% by mass, sufficient foam retention may not be achieved, and if it exceeds 2% by mass, insoluble hydroxypropyl methylcellulose may cause skin roughness at low temperatures.
[0024] 更に、上記ヒドロキシプロピルメチルセルロースを配合する場合は、(B)成分のヒド ロキシェチルセルロースの配合量に対して(D)成分のヒドロキシプロピルメチルセル ロースを質量比で 0. 06-2. 5、特に 0. 2〜2の割合となるように配合すること力 泡 保持性や使用感の点より好ましい。配合比が 0. 06未満では十分な泡保持性を付与 できない場合があり、 2. 5を超えると泡のきめ細かさが無くなり、更に曳糸性が生じる 場合がある。
[0025] また、本発明の歯磨組成物は、水分含量が 50質量%以下で、好ましくは 15〜40 質量%である。水分含量が 50質量%を超えると、初期及び経時の泡立ちが低下し、 更に曳糸性が生じる。 15質量%に満たないと不溶なヒドロキシェチルセルロース並 びにヒドロキシプロピルメチルセルロースが析出する場合がある。 [0024] Furthermore, when the above-mentioned hydroxypropyl methylcellulose is blended, the mass ratio of hydroxypropyl methylcellulose (D) to the blended amount of hydroxypropylcellulose (B) is 0.06-2. . 5, especially blending at a ratio of 0.2 to 2 is preferable from the viewpoint of foam retention and feeling of use. If the blending ratio is less than 0.06, it may not be possible to provide sufficient foam retention, and if it exceeds 2.5, the foam may lose its fineness and may become stringy. [0025] Furthermore, the dentifrice composition of the present invention has a water content of 50% by mass or less, preferably 15 to 40% by mass. When the water content exceeds 50% by mass, initial and temporal foaming decreases, and stringiness occurs. If the amount is less than 15% by mass, insoluble hydroxyethylcellulose and hydroxypropylmethylcellulose may precipitate.
[0026] 本発明の歯磨組成物は、ァ-オン性界面活性剤を実質的に含有しないものであり 、この場合、実質的に含有しないとは、歯磨組成中に含有しないことを意味する。 [0026] The dentifrice composition of the present invention does not substantially contain an ionic surfactant, and in this case, "substantially does not contain" means that it does not contain it in the dentifrice composition.
[0027] 本発明の歯磨組成物は、練歯磨、液体歯磨、液状歯磨、潤製歯磨等として調製で き、その剤型に応じ、上記必須成分に加えて本発明の効果を損なわない範囲で他の 任意成分を配合できる。例えば練歯磨の場合は、研磨剤、粘稠剤、粘結剤、界面活 性剤、甘味剤、防腐剤、有効成分、色素、香料等を配合でき、これら成分と水とを混 合し製造できる。 [0027] The dentifrice composition of the present invention can be prepared as a toothpaste, a liquid dentifrice, a liquid dentifrice, a moisturized dentifrice, etc. Depending on the dosage form, in addition to the above-mentioned essential ingredients, it may be added to a range that does not impair the effects of the present invention. Other optional ingredients can be added. For example, toothpaste can contain abrasives, thickeners, binders, surfactants, sweeteners, preservatives, active ingredients, pigments, fragrances, etc., and is manufactured by mixing these ingredients with water. can.
[0028] 研磨剤としては、沈降性シリカ、シリカゲル、アルミノシリケート、ジルコノシリケート、 第 2リン酸カルシウム 2水和物、第 2リン酸カルシウム無水和物、ピロリン酸カルシウム 、水酸ィ匕アルミニウム、アルミナ、 2酸化チタン、結晶性ジルコニウムシリケ一ト、ポリメ チルメタアタリレ—ト、不溶性メタリン酸カルシウム、軽質炭酸カルシウム、重質炭酸力 ルシゥム、炭酸マグネシウム、第 3リン酸マグネシウム、ゼォライト、ケィ酸ジルコニウム 、第 3リン酸カルシウム、ハイドロキシアパタイト、フルォロアパタイト、カルシウム欠損 アパタイト、第 3リン酸カルシウム、第 4リン酸カルシウム、第 8リン酸カルシウム、合成 榭脂系研磨剤などを、 1種又は 2種以上を組み合わせて配合することができる。配合 量は通常、組成物全量に対して 7〜60質量%である。 [0028] As the abrasive, precipitated silica, silica gel, aluminosilicate, zirconosilicate, dibasic calcium phosphate dihydrate, dibasic calcium phosphate anhydrate, calcium pyrophosphate, aluminum hydroxide, alumina, titanium dioxide , crystalline zirconium silicate, polymethyl metatallate, insoluble calcium metaphosphate, light calcium carbonate, heavy lucium carbonate, magnesium carbonate, tribasic magnesium phosphate, zeolite, zirconium silicate, tribasic calcium phosphate, hydroxyapatite, One type or a combination of two or more of fluoroapatite, calcium-deficient apatite, tertiary calcium phosphate, quaternary calcium phosphate, octai calcium phosphate, synthetic resin abrasive, etc. can be blended. The blending amount is usually 7 to 60% by mass based on the total amount of the composition.
[0029] 粘稠剤としては、グリセリン、ソルビット、プロピレングリコ一ル、分子量 200〜6000 のポリエチレングリコール、エチレングリコール、 1,3—ブチレングリコール、還元でん ぷん糖ィヒ物等の多価アルコール等の 1種又は 2種以上を組み合わせて配合すること ができる。配合量は通常、組成物全量に対して 5〜50質量%である。 [0029] Thickening agents include polyhydric alcohols such as glycerin, sorbitol, propylene glycoyl, polyethylene glycol with a molecular weight of 200 to 6000, ethylene glycol, 1,3-butylene glycol, and reduced starch sugars. It is possible to blend one type or a combination of two or more types. The blending amount is usually 5 to 50% by mass based on the total amount of the composition.
[0030] 粘結剤としては、上記(B)成分のヒドロキシェチルセルロース、 (D)成分のヒドロキ シプロピルメチルセルロース以外にも、塩ィ匕セチルピリジ-ゥムの活性を減じな ゾ- オン性又はカチオン性の粘結剤を配合でき、他のノ-オン性の粘結剤としては、例え ばメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース等が
挙げられる。カチオン性の粘結剤としては、カチオンィ匕ヒドロキシェチルセルロース等 が挙げられる。これらの粘結剤は、 1種単独で又は 2種以上を組み合わせて配合する ことができ、その配合量は、通常、組成物全量に対して 0. 1〜5質量%である。 [0030] In addition to the above-mentioned hydroxyethyl cellulose as component (B) and hydroxypropyl methyl cellulose as component (D), binders that do not reduce the activity of cetyl pyridium may also be used. Cationic binders can be added, and other non-ionic binders include methylcellulose, hydroxymethylcellulose, hydroxypropylcellulose, etc. Can be mentioned. Examples of the cationic binder include cationic hydroxyethylcellulose. These binders can be blended singly or in combination of two or more, and the blending amount is usually 0.1 to 5% by mass based on the total amount of the composition.
[0031] 界面活性剤としては、ァ-オン性界面活性剤を用いると組成物中での塩ィ匕セチル ピリジ-ゥムの殺菌活性を損なうおそれがあるため、ァ-オン性界面活性剤以外のも のが使用され、上記 (C)成分以外の両性界面活性剤、非イオン性界面活性剤、カチ オン性界面活性剤が挙げられる。本発明の必須構成要件である(C)成分以外の他 の両性界面活性剤としては、例えば N—ァシルグルタメート、 N—ミリスチルジアミノエ チルダリシン等の N—アルキルジアミノエチルダリシン等が挙げられる。非イオン性界 面活性剤としては、例えば酸ィ匕エチレンの付加モル数が 5〜80であるポリオキシェ チレン硬化ヒマシ油、酸化エチレンの付加モル数が 2〜25であり、アルキル鎖長の炭 素数が 10〜20であるポリオキシエチレンアルキルエーテル、アルキル鎖長の炭素数 力 ¾〜16であるアルキルグリコシド、ショ糖モノ及びジラウレート等の脂肪酸基の炭素 数が 12〜 18であるショ糖脂肪酸エステル、ラタトース脂肪酸エステル、ラタチトール 脂肪酸エステル、マルチトール脂肪酸エステル、ステアリン酸モノダリセライド、ポリオ キシエチレンソルビタンモノラウレート、ポリオキシエチレンソルビタンモノステアレート 、ラウロイルジェタノールアミド等のアルキロィルエタノールアミド、ポリオキシエチレン ポリオキシプロピレングリコール、ラウリン酸デカグリセリル等が挙げられる。これら界 面活性剤は、 1種単独又は 2種以上を組み合わせて配合することができ、その配合 量は、通常、組成物全量に対して 0. 1〜5質量%である。 [0031] As the surfactant, since using an ionic surfactant may impair the bactericidal activity of cetyl pyridium salt in the composition, use other than ionic surfactants. These include amphoteric surfactants, nonionic surfactants, and cationic surfactants other than the component (C) above. Other amphoteric surfactants other than component (C), which is an essential component of the present invention, include N-acylglutamate, N-alkyldiaminoethyldaricin such as N-myristyldiaminoethyldaricin, and the like. Nonionic surfactants include, for example, polyoxyethylene hydrogenated castor oil in which the number of added moles of ethylene oxide is 5 to 80, and polyoxyethylene hydrogenated castor oil in which the number of added moles of ethylene oxide is 2 to 25, and the number of carbon atoms in the alkyl chain length is 2 to 25. polyoxyethylene alkyl ether whose alkyl chain length is 10 to 20, alkyl glycoside whose alkyl chain length is ¾ to 16, sucrose fatty acid ester whose fatty acid group has 12 to 18 carbon atoms, such as sucrose mono- and dilaurate; Ratatose fatty acid ester, ratatitol fatty acid ester, maltitol fatty acid ester, stearic acid monodaliseride, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monostearate, alkylylethanolamide such as lauroyl jetanolamide, polyoxyethylene polyoxy Examples include propylene glycol and decaglyceryl laurate. These surfactants can be blended singly or in combination of two or more, and the blending amount is usually 0.1 to 5% by mass based on the total amount of the composition.
[0032] 甘味剤としては、サッカリンナトリウム、ァスパラテーム、ステピオサイド、ステビアェ キス、パラメトキシシンナミックアルデヒド、ネオヘスペリジルジヒドロカルコン、ペリラル チン等、防腐剤としては、ブチルパラベン、ェチルパラベン等のパラベン類、パラォキ シ安息香酸エステル、安息香酸ナトリウム等が挙げられる。なお、これら成分の配合 量は、本発明の効果を妨げない範囲で通常量とすることができる。 [0032] Sweeteners include saccharin sodium, asparatame, stepioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidyl dihydrochalcone, perilartine, etc. Preservatives include parabens such as butylparaben, ethylparaben, paraoxybenzoin, etc. Examples include acid esters, sodium benzoate, and the like. The blending amounts of these components can be set to normal amounts within a range that does not impede the effects of the present invention.
[0033] 塩ィ匕セチルピリジゥム以外の各種有効成分としては、例えばフッ化ナトリウム、フッ 化カリウム、フッ化第 1錫、フッ化ストロンチウム、モノフルォロリン酸ナトリウム等のフッ 化物、正リン酸のカリウム塩、ナトリウム塩等の水溶性リン酸ィ匕合物、トラネキサム酸、
ィプシロン-アミノカプロン酸、アラントインクロルヒドロキシアルミニウム、ヒノキチォー ル、ァスコルビン酸、塩ィ匕ナトリウム、酢酸 dl—トコフエロール、ジヒドロコレステロール 、 aービサボロール、クロルへキシジン塩類、ァズレン、グリチルレチン、グリチルレチ ン酸、銅クロロフィリンナトリウム、クロロフィル、グリセ口ホスフエ一トなどのキレ一ト性リ ン酸化合物、ダルコン酸銅等の銅化合物、乳酸アルミニウム、塩化ストロンチウム、硝 酸カリウム、ベルべリン、ヒドロキサム酸及びその誘導体、トリポリリン酸ナトリウム、ゼォ ライト、メトキシエチレン、無水マレイン酸共重合体、ポリビュルピロリドン、ェピジヒドロ コレステリン、塩化べンゼトニゥム、塩化ナトリウム、ジヒドロコレステロ一ル、トリクロロカ ルバ-リド、クェン酸亜鉛、トウキ軟エキス、ォゥバタエキス、力ミツレ、チヨウジ、ローズ マリー、ォゥゴン、ベニバナ等の抽出物などが挙げられる。配合量は有効量とすること ができる力 通常、組成物全量に対して 0. 001〜5質量%である。 [0033] Various active ingredients other than cetylpyridium salt include, for example, sodium fluoride, potassium fluoride, stannous fluoride, strontium fluoride, fluorides such as sodium monofluorophosphate, potassium salt of orthophosphoric acid, and sodium fluoride. Water-soluble phosphoric acid compounds such as salts, tranexamic acid, Epsilon-aminocaproic acid, allantoin chlorhydroxyaluminum, hinokitiol, ascorbic acid, sodium chloride, dl-tocopherol acetate, dihydrocholesterol, a-bisabolol, chlorhexidine salts, azulene, glycyrrhetinic acid, glycyrrhetinic acid, sodium copper chlorophyllin, chlorophyll , chelating phosphoric acid compounds such as griseite phosphate, copper compounds such as copper dalconate, aluminum lactate, strontium chloride, potassium nitrate, berberine, hydroxamic acid and its derivatives, sodium tripolyphosphate, Folite, methoxyethylene, maleic anhydride copolymer, polypyrrolidone, epidihydro cholesterin, benzethonium chloride, sodium chloride, dihydrocholesterol, trichlorocarbalide, zinc citrate, soft angelica extract, ovata extract, power Examples include extracts of honeysuckle, chiyoji, rosemary, sagebrush, safflower, etc. The blending amount is usually 0.001 to 5% by mass based on the total amount of the composition.
香料は、ペパーミント油、スペアミント油、ァニス油、ユーカリ油、ウィンターグリーン 油、カシア油、クローブ油、タイム油、セージ油、レモン油、オレンジ油、ハツ力油、力 ルダモン油、コリアンダー油、マンダリン油、ライム油、ラベンダー油、ローズマリー油 、ローレル油、カモミル油、キャラウェイ油、マジョラム油、べィ油、レモングラス油、オリ ガナム油、パインニードル油、ネロリ油、ローズ油、ジャスミン油、イリスコンクリート、ァ ブソリュートペパーミント、アブソリュートローズ、オレンジフラワー等の天然香料及び、 これら天然香料の加工処理 (前溜部カット、後溜部カット、分留、液液抽出、エッセン ス化、粉末香料化等)した香料、 及び、メントール、カルボン、ァネトール、シネオ一 ル、サリチル酸メチル、シンナミックアルデヒド、オイゲノール、 3—1—メントキシプロパ ンー 1. 2—ジオール、チモール、リナロール、リナリールアセテート、リモネン、メントン 、メンチルアセテート、 N—置換 パラメンタン一 3—カルボキサミド、ビネン、ォクチ ルアルデヒド、シトラール、プレゴン、カルビールアセテート、ァ-スアルデヒド、ェチ ルアセテート、ェチルブチレート、ァリルシクロへキサンプロピオネート、メチルアンス ラ-レート、ェチルメチルフエ-ルグリシデート、バニリン、ゥンデカラクトン、へキサナ ール、プロピルアルコール、ブタノール、イソアミルアルコール、へキセノール、ジメチ ルサルファイド、シクロテン、フルフラール、トリメチルビラジン、ェチルラタテート、メチ ルラクテート、ェチルチオアセテート等の単品香料、更に、ストロベリーフレーバー、
アップノレフレーノ一、ノ ナナフレーノ一、ノ ィナップノレフレーノ一、グレープフレー ノ一、マンゴーフレーノ一、ノ ターフレーノ一、ミノレクフレーノ一、フノレーッミックスフ レーバー、トロピカルフルーツフレーバー等の調合香料等、歯磨組成物に用いられる 公知の香料素材を使用することができ、実施例の香料に限定されない。 Fragrances include peppermint oil, spearmint oil, anise oil, eucalyptus oil, wintergreen oil, cassia oil, clove oil, thyme oil, sage oil, lemon oil, orange oil, chili oil, rhudamon oil, coriander oil, mandarin oil. , lime oil, lavender oil, rosemary oil, laurel oil, chamomile oil, caraway oil, marjoram oil, bean oil, lemongrass oil, origanum oil, pine needle oil, neroli oil, rose oil, jasmine oil, iris oil Natural fragrances such as concrete, absolute peppermint, absolute rose, orange flower, etc., and the processing of these natural fragrances (front distillation cut, rear distillation cut, fractional distillation, liquid-liquid extraction, essence production, powder fragrance production, etc.) ) and menthol, carvone, phanethole, cineole, methyl salicylate, cinnamic aldehyde, eugenol, 3-1-menthoxypropane-1.2-diol, thymol, linalool, linary acetate, limonene, menthone , menthyl acetate, N-substituted para-menthane-3-carboxamide, binene, octyraldehyde, citral, pulegone, carbyl acetate, arsaldehyde, ethyl acetate, ethyl butyrate, allylcyclohexanepropionate, methyl anthralate , ethyl methyl phenol glycidate, vanillin, undecalactone, hexanal, propyl alcohol, butanol, isoamyl alcohol, hexenol, dimethyl sulfide, cyclotene, furfural, trimethylvirazine, ethyl latatate, methyl lactate, ethyl thioacetate, etc. , furthermore, strawberry flavor, Compounded fragrances such as Upnorefreno-ichi, No-Nanafreno-ichi, No-Nup-Norefreno-ichi, Grape Flavorino-ichi, Mango Freno-ichi, Notafureno-ichi, Minorekfureno-ichi, Funoret Mix Flavor, Tropical Fruit Flavor, etc. Any known flavoring material used in dentifrice compositions can be used, and is not limited to the flavoring materials in the Examples.
[0035] また、香料の配合量も特に限定されないが、上記の香料素材は、製剤組成中に 0. [0035]Although the blending amount of the fragrance is not particularly limited, the above fragrance materials may be included in the formulation composition in an amount of 0.
000001〜1質量%使用することが好ましい。また、上記香料素材を使用した賦香用 香料としては、製剤組成中に 0. 1〜2. 0質量%使用することが好ましい。 It is preferable to use 000001 to 1% by mass. In addition, it is preferable to use 0.1 to 2.0% by mass of the perfume material in the formulation composition as a perfume for flavoring using the above-mentioned perfume material.
[0036] 着色剤としては、青色 1号、責色 4号、緑色 3号等が例示される。なお、これら成分 の配合量は、本発明の効果を妨げない範囲で通常量とすることができる。 [0036] Examples of the coloring agent include Blue No. 1, Shinshoku No. 4, and Green No. 3. The blending amounts of these components can be set to normal amounts within a range that does not impede the effects of the present invention.
実施例 Example
[0037] 以下、実施例及び比較例を示し、本発明の歯磨組成物に該当する組成例(実施例 )及び該当しない組成例 (比較例)を用いた殺菌力試験、泡高試験、使用感、曳糸性 の評価結果を示し、本発明の特徴及び優れた効果を具体的に説明するが、本発明 は以下の実施例に制限されるものではない。以下の例において配合量はいずれも質 量%であり、配合比は質量比である。 [0037] Examples and comparative examples are shown below, including a bactericidal power test, a foam height test, and a feeling of use using a composition example (example) that corresponds to the dentifrice composition of the present invention and a composition example that does not correspond (comparative example). The characteristics and excellent effects of the present invention will be specifically explained by showing the evaluation results of stringability, but the present invention is not limited to the following examples. In the following examples, the blending amounts are all mass %, and the blending ratios are mass ratios.
[0038] 〔実施例 1〜8、比較例 1〜7〕 [0038] [Examples 1 to 8, Comparative Examples 1 to 7]
表 1, 2に示した成分を配合した試験練歯磨剤を常法により調製し、殺菌力試験、 泡高試験、使用感(口中での泡立ち、苦味のなさ、粘膜刺激)、曳糸性を以下の方法 により評価した。結果を表 1, 2に示す。なお、これらの歯磨組成物の調製には、塩ィ匕 セチルピリジ-ゥム(和光純薬工業 (株))、ヒドロキシェチルセルロース (ダイセル化学 工業 (株) HEC EE— 820 重量平均分子量 130万)、ラウリルジメチルァミノ酢酸 ベタイン(日光ケミカルズ (株) NIKKOL AM— 301)、 2—ヤシ油アルキル— N— カルボキシメチル一 N—ヒドロキシェチルイミダゾリ-ゥムベタインナトリウム(ライオン( 株) ェナジコール C— 40H)、ヤシ油脂肪酸アミドプロピルべタイン(Degussa.社 TEGO BetainCK)を用いた。他成分については、ラウリル硫酸ナトリウム、歯磨用 リン酸水素カルシウム · 2水和物、無水ケィ酸、酸化チタン、ポリエチレングリコール 40 0、カルボキシメチルセルロースナトリウム、カラギーナン、ポリオキシエチレン(20)硬 ィ匕ヒマシ油、サッカリンナトリウム、 85%グリセリン、精製水は化粧品原料基準規格品
、モノフルォロリン酸ナトリウムは医薬部外品原料規格規格品を用いた。 Test toothpastes containing the ingredients listed in Tables 1 and 2 were prepared using conventional methods, and tested for bactericidal activity, foam height, usability (foaming in the mouth, lack of bitterness, mucous membrane irritation), and stringability. It was evaluated using the following method. The results are shown in Tables 1 and 2. In addition, for the preparation of these toothpaste compositions, cetylpyridium salt (Wako Pure Chemical Industries, Ltd.), hydroxyethyl cellulose (Daicel Chemical Industries, Ltd., HEC EE—820, weight average molecular weight 1.3 million) are used. , lauryldimethylaminoacetic acid betaine (Nikko Chemicals Co., Ltd. NIKKOL AM— 301), 2-coconut oil alkyl- N-carboxymethyl-N-hydroxyethylimidazolium betaine sodium (Lion Co., Ltd. enadicol C— 40H) and coconut oil fatty acid amidopropyl betaine (TEGO BetainCK, Degussa.). Other ingredients include sodium lauryl sulfate, toothpaste calcium hydrogen phosphate dihydrate, silicic anhydride, titanium oxide, polyethylene glycol 400, sodium carboxymethyl cellulose, carrageenan, polyoxyethylene (20) hardened castor oil. , saccharin sodium, 85% glycerin, and purified water are cosmetic raw material standard products. For sodium monofluorophosphate, a quasi-drug raw material standard product was used.
[0039] 〔実施例 9〜16〕 [0039] [Examples 9 to 16]
表 3に示した成分を配合した試験歯磨剤を常法により調製し、殺菌力試験、泡高試 験、使用感(口中での泡立ち、苦味のなさ、粘膜刺激、泡のきめ細力さ)、曳糸性を 以下の方法により評価した。結果を表 3に示す。なお、これらの歯磨組成物の調製に は、塩ィ匕セチルピリジ-ゥム (和光純薬工業 (株))、ヒドロキシェチルセルロース (ダイ セル化学工業 (株) HEC EE— 820 重量平均分子量 130万)、ヒドロキシプロピ ルメチルセルロース(信越化学工業 (株) メトローズ 60SH— 50 20°C粘度 50mPa • s)、ラウリルジメチルァミノ酢酸べタイン(日光ケミカルズ (株) NIKKOL AM— 30 1)、 N—ヤシ油脂肪酸ァシルー N—カルボキシメチルー N ヒドロキシェチルイミダ ゾリ-ゥムベタイン (ライオン (株) ェナジコール C 40H)、ヤシ油脂肪酸アミドプロ ピルべタイン(Degussa.社 TEGO BetainCK)を用いた。他成分については、歯 磨用リン酸水素カルシウム · 2水和物、無水ケィ酸、酸化チタン、ポリエチレングリコー ル 400、ポリオキシエチレン(20)硬化ヒマシ油、サッカリンナトリウム、 85%グリセリン 、精製水は粧原基規格品、モノフルォロリン酸ナトリウムは外原規規格品を用いた。 A test dentifrice containing the ingredients listed in Table 3 was prepared using a conventional method, and tested for bactericidal activity, foam height, and usability (foaming in the mouth, lack of bitterness, mucous membrane irritation, fineness of the foam). The stringiness was evaluated by the following method. The results are shown in Table 3. In the preparation of these toothpaste compositions, cetylpyridium salt (Wako Pure Chemical Industries, Ltd.), hydroxyethyl cellulose (Daicel Chemical Industries, Ltd.), HEC EE—820, weight average molecular weight 1.3 million, were used. ), hydroxypropyl methylcellulose (Shin-Etsu Chemical Co., Ltd. Metrose 60SH— 50 20°C viscosity 50 mPa • s), lauryl dimethylaminoacetic acid betaine (Nikko Chemicals Co., Ltd. NIKKOL AM— 30 1), N—coconut oil Fatty acid acyl-N-carboxymethyl-N-hydroxyethylimidazolium betaine (Lion Co., Ltd., enadicol C 40H) and coconut oil fatty acid amidopropyl betaine (Degussa., TEGO BetainCK) were used. Other ingredients include calcium hydrogen phosphate dihydrate for toothpaste, silicic anhydride, titanium oxide, polyethylene glycol 400, polyoxyethylene (20) hydrogenated castor oil, sodium saccharin, 85% glycerin, and purified water. The standard standard product, sodium monofluorophosphate, was an external standard standard product.
[0040] (1)殺菌力試験の評価方法 [0040] (1) Evaluation method of bactericidal activity test
凍結保存してあったボルフイロモーナス ジンジバリス培養液 40 μ Lをそれぞれ 5m gZLへミン (Sigma社製)及び lmgZLビタミン K (和光純薬工業社製)を含むトッド へ一ウィットブロース(Becton and Dickinson社製)培養液(THBHM) 4mLに添 加し、 37°Cでニ晚嫌気培養(80vol%窒素、 10vol%二酸ィ匕炭素、 10vol%水素)し 菌液とした。表 1〜3の歯磨剤を作成し、歯磨剤 lgに THBHM培地 49mLを加え攪 拌した後、さらに THBHM培地をカ卩ぇ歯磨剤希釈倍率として 400〜2, 400倍となる ように各々の歯磨剤希釈培地を作成した。各々の歯磨剤希釈培地 3mLに菌液 50 μ Lを添加し、 37°Cで 10日間嫌気培養後、菌の生育の有無を外観、におい、顕微鏡を 用いて判定した。なお、殺菌力は菌の生育が見られな力つた最高希釈度で示した。 40 μL of frozen Boruphyromonas gingivalis culture was added to Becton and Dickinson broth containing 5 m gZL hemin (Sigma) and lmgZL vitamin K (Wako Pure Chemical Industries, Ltd.). The bacteria were added to 4 mL of culture solution (THBHM) and cultured anaerobically at 37°C for two nights (80 vol% nitrogen, 10 vol% carbon dioxide, 10 vol% hydrogen) to obtain a bacterial solution. Prepare the dentifrices listed in Tables 1 to 3, add 49 mL of THBHM medium to dentifrice lg, stir, and then add THBHM medium to dilute each toothpaste so that the dilution ratio is 400 to 2,400 times. A drug dilution medium was prepared. 50 μL of the bacterial solution was added to 3 mL of each dentifrice dilution medium, and after anaerobic culture at 37°C for 10 days, the presence or absence of bacterial growth was determined using appearance, smell, and microscopy. The bactericidal activity was expressed as the highest dilution at which no bacterial growth was observed.
[0041] (2)泡高試験の評価方法 [0041] (2) Evaluation method of foam height test
表 1〜3の歯磨剤を作成し、人口唾液 10mLに対し歯磨剤 lgを加え、分散し、分散 液とした。分散液を lOOmLのネスラー管にとり、 10秒間で 20回激しく振とうし、直後
、並びに 10分静置後の泡の高さをネスラー管の mL値を用いて泡高試験値として示 した。なお、人工唾液としては、 3. 73gの塩ィ匕カリウム、 0. 14gのリン酸 2水素 1力リウ ム、 0. 15gの塩化カルシウム · 2水和物、 0. 02gの塩化マグネシウム · 6水和物を精 製水に溶解し、水酸ィ匕カリウムで pHを 7に調製し、 lOOOmLとしたものを使用した。 The dentifrices shown in Tables 1 to 3 were prepared, and 1g of dentifrice was added to 10mL of artificial saliva and dispersed to form a dispersion liquid. Transfer the dispersion to a lOOmL Nessler tube, shake vigorously 20 times for 10 seconds, and immediately , and the foam height after 10 minutes of standing was shown as the foam height test value using the mL value of the Nessler tube. In addition, the artificial saliva includes 3.73g of potassium salt, 0.14g of dihydrogen phosphate, 0.15g of calcium chloride dihydrate, and 0.02g of magnesium chloride hexahydrate. The solution was dissolved in purified water, the pH was adjusted to 7 with potassium hydroxide, and the solution was used.
[0042] (3)使用感(口中での泡立ち)の評価方法 [0042] (3) Evaluation method for feeling of use (foaming in the mouth)
表 1〜3の歯磨剤を作成し、被験者 10名を用いて、歯磨剤約 lgを市販品歯ブラシ にのせて 3分間ブラッシングを行い、口中での泡立ちを以下の基準で官能評価し平 均値を求めた。なお、泡立ちの対照サンプルとして比較例 5のサンプルを使用し、こ れを基準とし評価を行った。 The toothpastes shown in Tables 1 to 3 were prepared, and 10 subjects placed about 1g of the toothpaste on a commercially available toothbrush and brushed for 3 minutes.The foaming in the mouth was sensory-evaluated using the following criteria and the average value was evaluated. I asked for Note that the sample of Comparative Example 5 was used as a control sample for foaming, and evaluation was performed using this as a standard.
[0043] (評点) [0043] (Rating)
4点:対照サンプルと比較して非常に良!ヽ 4 points: Very good compared to the control sample!ヽ
3点:対照サンプルと比較して良!ヽ 3 points: Good compared to the control sample!ヽ
2点:対照サンプルと比較してやや良!、 2 points: Slightly better than the control sample!
1点:対照サンプルと比較して同等以下 1 point: Equal or lower than the control sample
(評価基準) (Evaluation criteria)
◎:平均点 3. 5点以上 4. 0点以下 ◎: Average score 3. 5 points or more 4. 0 points or less
〇:平均点 3. 0点以上 3. 5点未満 〇:Average score 3. 0 points or more 3. Less than 5 points
Δ :平均点 2. 0点以上 3. 0点未満 Δ: Average score 2. 0 points or more 3. Less than 0 points
X:平均点 1. 0点以上 2. 0点未満 X: Average score 1. 0 points or more 2. Less than 0 points
[0044] (4)使用感(苦味のなさ)の評価方法 [0044] (4) Evaluation method of usability (lack of bitterness)
表 1〜3の歯磨剤を作成し、被験者 10名を用いて、歯磨剤約 lgを市販品歯ブラシ にのせて 3分間ブラッシングを行い、使用中に感じた苦味を、「ない」、「ややある」、「 ある」、の 3段階で回答を得た。この回答のうち、「ない」を 3点、「ややある」を 2点、「あ る」を 1点として、 10名の平均点から以下の基準で使用感を評価した。 The toothpastes listed in Tables 1 to 3 were prepared, and 10 subjects placed about 1g of the dentifrice on a commercially available toothbrush and brushed for 3 minutes. Responses were given on a three-point scale: "Yes" and "Yes." Of these answers, 3 points were given for ``no,'' 2 points were given for ``somewhat,'' and 1 point were given for ``yes.'' The usability was evaluated using the following criteria based on the average score of the 10 respondents.
(評価基準) (Evaluation criteria)
◎:平均点 2. 5点以上 3. 0点以下 ◎: Average score 2. 5 points or more 3. 0 points or less
〇:平均点 2. 0点以上 2. 5点未満 〇:Average score 2. 0 points or more 2. Less than 5 points
Δ :平均点 1. 5点以上 2. 0点未満
X :平均点 1. 0点以上 1. 5点未満 Δ: Average score 1. 5 points or more 2. Less than 0 points X: Average score 1. 0 points or more 1. Less than 5 points
[0045] (5)使用感 (粘膜刺激)の評価方法 [0045] (5) Evaluation method for usability (mucosal irritation)
表 1〜3の歯磨剤を作成し、粘膜刺激に敏感な被験者 10名を用いて、歯磨剤約 lg を市販品歯ブラシにのせて 3分間ブラッシングを行 、、使用中に感じた粘膜刺激を以 下の基準で官能評価し平均値を求めた。なお、粘膜刺激の対照サンプルとしてラウリ ル硫酸ナトリウムを配合した比較例 4のサンプルを使用し、これを基準とし評価を行つ た。 The dentifrices listed in Tables 1 to 3 were prepared, and 10 test subjects who were sensitive to mucosal irritation were asked to put about 1g of the dentifrice on a commercially available toothbrush and brush for 3 minutes. Sensory evaluation was performed using the criteria below and the average value was determined. Furthermore, as a control sample for mucosal irritation, the sample of Comparative Example 4 containing sodium lauryl sulfate was used, and evaluation was performed using this as a standard.
[0046] (評点) [0046] (Rating)
4点:対照サンプルと比較して非常に良!ヽ 4 points: Very good compared to the control sample!ヽ
3点:対照サンプルと比較して良!ヽ 3 points: Good compared to the control sample!ヽ
2点:対照サンプルと比較してやや良!、 2 points: Slightly better than the control sample!
1点:対照サンプルと比較して同等以下 1 point: Equal or lower than the control sample
(評価基準) (Evaluation criteria)
◎:平均点 3. 5点以上 4. 0点以下 ◎: Average score 3. 5 points or more 4. 0 points or less
〇:平均点 3. 0点以上 3. 5点未満 〇:Average score 3. 0 points or more 3. Less than 5 points
Δ :平均点 2. 0点以上 3. 0点未満 Δ: Average score 2. 0 points or more 3. Less than 0 points
X:平均点 1. 0点以上 2. 0点未満 X: Average score 1. 0 points or more 2. Less than 0 points
[0047] (6)曳糸性の評価方法 [0047] (6) Evaluation method of stringiness
表 1〜3の歯磨剤を作成し、口径 8mmの 90gチューブに 60g充填した。更紙上に 1 cm歯磨剤を出した後、チューブ口元を押し付け、垂直に上へと引き上げた時の糸を 引いた高さを曳糸性評価として以下の基準で評価した。 The dentifrices shown in Tables 1 to 3 were prepared and 60g was filled into a 90g tube with a diameter of 8mm. After dispensing 1 cm of toothpaste onto the paper, the mouth of the tube was pressed and the height of the thread when pulled up vertically was evaluated according to the following criteria as stringability evaluation.
(評価基準) (Evaluation criteria)
◎:糸の高さが 1. Ocm未満 ◎: Thread height is less than 1.Ocm
〇:糸の高さが 1. Ocm以上 2. Ocm未満 〇: Thread height is 1.Ocm or more but less than 2.Ocm
△:糸の高さが 2. Ocm以上 3. Ocm未満 △: Thread height is 2. Ocm or more but less than 3. Ocm
X:糸の高さが 3. Ocm以上 X: Thread height is 3.Ocm or more
[0048] (7)使用感 (泡のきめ細かさ)の評価方法 [0048] (7) Evaluation method of usability (fineness of foam)
表 3の歯磨剤を作成し、被験者 10名を用いて、歯磨剤約 lgを市販品歯ブラシにの
せて 3分間ブラッシングを行い、口腔内での泡のきめ細かさを、「非常に良い」、「やや 良い」、「どちらとも言えない」、「やや悪い」、「悪い」の 5段階で回答を得た。この回答 のうち、「非常に良い」を 5点、「やや良い」を 4点、「どちらとも言えない」を 3点、「やや 悪い」を 2点、「悪い」を 1点として、 10名の平均点から以下の基準で使用感を評価し た。 The dentifrice shown in Table 3 was prepared and 10 subjects were asked to apply approximately 1 g of the dentifrice to a commercially available toothbrush. After brushing for 3 minutes, students were asked to rate the fineness of the bubbles in their mouths on a five-point scale: ``very good,'' ``somewhat good,''``neutral,'' ``somewhat bad,'' and ``poor.'' Obtained. Of these responses, 10 people gave 5 points for "very good," 4 points for "somewhat good," 3 points for "neutral," 2 points for "somewhat bad," and 1 point for "poor." The usability was evaluated using the following criteria based on the average score.
◎:平均点 4. 0点以上 5. 0点以下 ◎: Average score 4. 0 points or more 5. 0 points or less
〇:平均点 3. 0点以上 4. 0点未満 〇:Average score 3. 0 points or more 4. Less than 0 points
Δ :平均点 2. 0点以上 3. 0点未満 Δ: Average score 2. 0 points or more 3. Less than 0 points
X:平均点 1. 0点以上 2. 0点未満 X: Average score 1. 0 points or more 2. Less than 0 points
[表 1]
[table 1]
実施例 Example
組 成 (%) Composition (%)
1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8
(A) 塩化セチルピリ ニゥム 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05(A) Cetylpyrinium chloride 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05
(B) ヒト、、口キンェチルセルロース 0. 8 0. 8 0. 8 0. 9 1. 5 1. 4 0. 5 1. 2 ラウリ;レシ'メチ;レアミノ酢酸 (B) Human quincetylate cellulose 0. 8 0. 8 0. 8 0. 9 1. 5 1. 4 0. 5 1. 2 Lauri; Reci'meth; Rare aminoacetic acid
0. 6 0. 4 1. 4 タイン(*1) 0. 6 0. 4 1. 4 Tine (*1)
2-ヤシ油アルキル- N-か 2-coconut alkyl-N-?
キンメチルー N ヒ卜 ロキシェチル Kinmetyl-N
(0 0. 6 0. 5 0. 1 (0 0. 6 0. 5 0. 1
イミ ソ、、!]ニゥム 、タインナト Im so...! ] Nium, Taynat
リウム(*2) Rium (*2)
ヤシ油脂肪酸アミドフ"口 Coconut oil fatty acid amide
- - 0. 6 - - - - 0. 2 ヒ。ル 、タイン(*3) - - 0. 6 - - - - 0. 2 h. Le, Tine (*3)
(C) / (B) 0, 75 0. 75 0. 75 0. 56 0, 27 0. 07 2. 80 0. 1 7 ラウリル硫酸ナトリウム - - - - - - - - 歯磨用 ン酸水素カルシクム · 2水和 (C) / (B) 0, 75 0. 75 0. 75 0. 56 0, 27 0. 07 2. 80 0. 1 7 Sodium lauryl sulfate - - - - - - - - For toothpaste Calcicum hydrogen phosphate · dihydration
45 45 45 35 25 25 50 45 物 45 45 45 35 25 25 50 45 things
無水ケィ酸 3 3 3 4 5 5 5 3 酸化チタン 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 リエチレン; リコール 400 3 3 3 3 3 3 3 3 カル ''キシメチルセルロースナトリウム Silicic anhydride 3 3 3 4 5 5 5 3 Titanium oxide 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 Liethylene; Recall 400 3 3 3 3 3 3 3 3 Cal ''xymethylcellulose sodium
カラキ ナン - - - - - - - - ί'リオ: tシエチレン(20)硬化ヒマシ油 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 サッカリンナトリウム 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 モノフルォロリン酸ナトリウム 0. 73 0. 73 0. 73 0. 73 0. 73 0. 73 0. 73 0. 73 香料 1 1 1 1 1 1 1 1Karakinan - - - - - - - - ί'rio: t-ethylene (20) hydrogenated castor oil 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 Sodium saccharin 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 Sodium monofluorophosphate 0. 73 0. 73 0. 73 0. 73 0. 73 0. 73 0. 73 0. 73 Fragrance 1 1 1 1 1 1 1 1
85%Γリセリン 20 20 20 20 16 20 20 20 精製水 24. 72 24. 72 24. 72 33. 72 46. 22 42. 62 17. 22 24. 72 計 100 100 100 100 100 100 100 100 水分含量(*4) 27. 72 27. 72 27. 72 36. 72 48. 62 45. 62 20. 22 21. 12 殺菌力 1600 1600 1600 1600 1600 1600 1600 1600 y包 ift s^ 直後 44 46 42 44 40 34 36 42 験 (mL) 10分間静笸後 30 34 32 32 32 28 32 32 口中での泡立ち 〇 © 0 〇 〇 〇 〇 〇 使用感 苦味のなさ © © @ 〇 85% lyserine 20 20 20 20 16 20 20 20 Purified water 24. 72 24. 72 24. 72 33. 72 46. 22 42. 62 17. 22 24. 72 Total 100 100 100 100 100 100 100 1 00 Moisture content ( *4) 27. 72 27. 72 27. 72 36. 72 48. 62 45. 62 20. 22 21. 12 Sterilizing power 1600 1600 1600 1600 1600 1600 1600 1600 Y packet ift s^ Immediately after 44 46 42 44 40 34 36 42 Test (mL) After 10 minutes of stillness 30 34 32 32 32 28 32 32 Foaming in the mouth 〇 © 0 〇 〇 〇 〇 〇 Feeling of use No bitterness © © @ 〇
粘膜刺激 © @ © Mucosal irritation © @ ©
曳糸性 @ @ 〇 〇 〇 表 2]
比較例 Threadability @ @ 〇 〇 〇 Table 2] Comparative example
組 成 (%) Composition (%)
1 2 3 4 5 6 7 1 2 3 4 5 6 7
(A) 塩化セチルビリシ'ニゥム 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05(A) Cetyl bilicinium chloride 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05 0. 05
(B) ヒト-'ロキシェチルセルロース 0. 8 1. 0 0. 8 1. 0 0. 9 ラウリルシ メチルァミノ酢酸へ"タイ (B) Human-'loxethyl cellulose 0. 8 1. 0 0. 8 1. 0 0. 9 Lauryl methylaminoacetic acid
4 Four
ン(*1) (*1)
2-ヤシ油アルキル- ル ί、'キシメ 2-Cocoalkyl ί,'kisime
(c) チル -N-tドロキシェチルイ W、) 0. 02 0. 5 リニゥム タインナトリウム(*2) (c) Chill-N-tDrokishetyrui W, ) 0. 02 0. 5 Linium Tine Sodium (*2)
ヤシ油脂肪酸アミト"フ ' pピル Coconut oil fatty acid amide pill
0. 6 へ、、タイン(*3) 0.6 to tine (*3)
(C) / (B) 0. 02 5. 00 0. 56 ラウリル硫酸ナトリウム 0. 8 (C) / (B) 0. 02 5. 00 0. 56 Sodium lauryl sulfate 0. 8
歯磨用リン酸水素か H/クム · 2水和物 45 45 45 45 45 45 20 無水ケィ酸 3 3 3 3 3 3 5 酸化チタン 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 ホ。リエチレンク'リコール 400 3 3 3 3 3 3 3 カルホ キシメチルセルロースナトリウム 1 1 カラキ■' ナン 0. 2 0. 2 ホ'リオキシヱチレン(20)硬ィ匕ヒマシ油 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 サッカリンナトリウム 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 モノフルォロリン酸ナトリウム 0. 73 0. 73 0. 73 0. 73 0. 73 0. 73 0. 73 香科 1 1 1 1 1 1 1 Hydrogen phosphate for toothpaste or H/cum dihydrate 45 45 45 45 45 45 20 Silicic anhydride 3 3 3 3 3 3 5 Titanium oxide 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 ho. Liethylene glycol 400 3 3 3 3 3 3 3 Sodium carboxymethyl cellulose 1 1 Karaki Nan 0. 2 0. 2 Polyoxyethylene (20) hard castor oil 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 0. 7 Sodium saccharin 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 0. 2 Sodium monofluorophosphate 0. 73 0. 73 0. 73 0. 73 0. 73 0 . 73 0. 73 Aromaceae 1 1 1 1 1 1 1
85%ク リセリン 20 20 20 20 20 20 14 精製水 25. 32 25. 10 21. 32 24. 32 24. 92 24. 32 53. 72 計 100 100 100 100 100 100 100 水分含量(*4) 28. 32 28. 10 24. 32 27. 32 27. 92 27. 32 55. 82 殺菌力 1200 1600 1200 400 400 400 1200 泡高試験 直後 20 24 32 44 12 20 26 (mL) 10分間静置後 18 20 24 34 12 12 24 口中での泡立ち X X Δ 〇 X X 使用感 苦味のなさ © © X 0 Δ 〇 粘膜刺激 Δ Δ Δ △ © O 曳糸性 Δ 0 X Δ 0 O X 85% Chrycerin 20 20 20 20 20 20 14 Purified water 25. 32 25. 10 21. 32 24. 32 24. 92 24. 32 53. 72 Total 100 100 100 100 100 100 100 Water content (*4) 28. 32 28. 10 24. 32 27. 32 27. 92 27. 32 55. 82 Bactericidal power 1200 1600 1200 400 400 400 1200 Immediately after foam height test 20 24 32 44 12 20 26 (mL) After standing for 10 minutes 18 20 24 34 12 12 24 Foaming in the mouth X X Δ 〇 X
[0051] * 1:35%品を用い、表中の値は純分換算した配合量を示した。 [0051] * A 1:35% product was used, and the values in the table indicate the blended amount in terms of pure content.
* 2:30%品を用い、表中の値は純分換算した配合量を示した。 * A 2:30% product was used, and the values in the table show the blended amount converted to pure content.
* 3:30%品を用い、表中の値は純分換算した配合量を示した。 * A 3:30% product was used, and the values in the table indicate the blended amount converted to pure content.
* 4: 85%グリセリンに含まれる水分及び精製水の合計量。 * 4: Total amount of water and purified water contained in 85% glycerin.
[0052] (A)塩化セチルピリジ-ゥム、(B)ヒドロキシェチルセルロース、 (C)成分の特定の 両性界面活性剤を含有し、(B)成分に対する (C)成分の配合比が質量比で 0. 06〜 3で、組成物中の水分含量が 50質量%以下であり、ァ-オン性界面活性剤を含有し
ない歯磨組成物(実施例 1 8)は、塩ィ匕セチルピリジ-ゥム由来の高い殺菌力を有 する上、発泡性能や味、使用感を損なわず、かつ粘膜刺激のないことを確認した。 [0052] Contains (A) cetylpyridium chloride, (B) hydroxyethylcellulose, and (C) a specific amphoteric surfactant, and the blending ratio of component (C) to component (B) is the mass ratio. 0.06 to 3, the water content in the composition is 50% by mass or less, and the composition contains an aionic surfactant. It was confirmed that the dentifrice composition (Example 1-8), which does not contain any sulfuric acid, has high bactericidal activity derived from cetylpyridium salt, does not impair foaming performance, taste, or feeling of use, and does not irritate mucous membranes.
[表 3] [Table 3]
* 1:35%品を用い、表中の値は純分換算した配合量を示した。 * A 1:35% product was used, and the values in the table indicate the blended amount converted to pure content.
* 2:30%品を用い、表中の値は純分換算した配合量を示した。 * A 2:30% product was used, and the values in the table indicate the blended amount converted to pure content.
* 3:30%品を用い、表中の値は純分換算した配合量を示した。 * A 3:30% product was used, and the values in the table indicate the blended amount converted to pure content.
* 4: 85%グリセリンに含まれる水分及び精製水の合計量。
[0055] なお、上記組成において、香料については、表 4に示す香料(表 4中のフレーバー 組成は表 5に示すとおりである。)を作成し、配合した。 * 4: Total amount of water and purified water contained in 85% glycerin. [0055] In the above composition, the flavors shown in Table 4 (the flavor compositions in Table 4 are as shown in Table 5) were prepared and blended.
[0056] [表 4] [0056] [Table 4]
香料組成 Fragrance composition
(表中の数字は香料組成物全量に対する質量%) (The numbers in the table are mass% based on the total amount of fragrance composition)
[0057] [表 5] [0057] [Table 5]
フレーバー組成 flavor composition
(表中の部は質量部)
[0058] (A)塩化セチルピリジ-ゥム、(B)ヒドロキシェチルセルロース、(C)成分の特定の 両性界面活性剤、更には(D)ヒドロキシプロピルメチルセルロースを含有し、(B)成 分に対する(C)成分の配合割合が質量比が 0. 06〜3で、組成物中の水分含量が 5 0質量%以下であり、(B)成分に対する(D)成分の質量比が 0. 06-2. 5である歯 磨組成物(実施例 9〜16)は、塩ィ匕セチルピリジ-ゥム由来の高い殺菌力を有し、し 力も、発泡性能や味、使用感を損なわず、粘膜刺激のないこと、並びに泡保持性、泡 のきめ細かさが高いことを確認した。 (Parts in the table are parts by mass) [0058] Contains (A) cetylpyridium chloride, (B) hydroxyethylcellulose, (C) a specific amphoteric surfactant as component, and further contains (D) hydroxypropylmethylcellulose, and The mass ratio of component (C) is 0.06-3, the water content in the composition is 50% by mass or less, and the mass ratio of component (D) to component (B) is 0.06-3. 2. The toothpaste compositions (Examples 9 to 16) of 5 have high bactericidal activity derived from cetylpyridium salt, and do not impair foaming performance, taste, or feeling of use, and do not cause irritation to mucous membranes. It was confirmed that there was no foam, and that the foam retention and fineness of the foam were high.
[0059] 〔実施例 17〕練歯磨 [0059] [Example 17] Toothpaste
塩化セチルピリジ-ゥム 0. 02% Cetylpyridium chloride 0.02%
イソプロピルメチルフエノール 0. 05 Isopropylmethylphenol 0.05
ヒドロキシェチノレセノレロース 1. 0 Hydroxyethinoresenolose 1.0
ヒドロキシプロピルメチルセルロース 0. 2 Hydroxypropyl methylcellulose 0.2
ポリオキシエチレン(20)硬化ヒマシ油 1. 0 Polyoxyethylene (20) hydrogenated castor oil 1.0
2 -ヤシ油アルキル— N—カルボキシメチル - N—ヒドロキシェチノレイミダゾリ-ゥムベタインナトリウム(* 1) 0. 6 2-Coconut oil alkyl- N-carboxymethyl- N-hydroxyethynoleimidazolium betaine sodium (* 1) 0. 6
歯磨用リン酸水素カルシウム · 2水和物 45 Calcium hydrogen phosphate dihydrate for toothpaste 45
85%グリセリン 18 85% Glycerin 18
サッカリンナトリウム 0. 2 Saccharin sodium 0.2
ポリオキシエチレングリコール 400 3. 0 Polyoxyethylene glycol 400 3. 0
ノ ラオキシ安息香酸メチル 0. 06 Methyl Noraoxybenzoate 0.06
パラォキシ安息香酸ブチル 0. 01 Butyl paraoxybenzoate 0.01
酸化チタン 0. 3 Titanium oxide 0.3
モノフルォロリン酸ナトリウム 0. 73 Sodium monofluorophosphate 0.73
香料 1. 0 Fragrance 1.0
2t 28. 83 2t 28. 83
計 100.0% Total 100.0%
* 1 : 30%品を用い、純分換算した配合量を示した。 *1: Using a 30% product, the blended amount is shown in terms of pure content.
(C) / (B) : 0. 6
(D) / (C) : 0. 2 (C) / (B) : 0.6 (D) / (C) : 0. 2
水分量: 31. 53質量% Moisture content: 31.53% by mass
上記の歯磨組成物は、塩ィ匕セチルピリジ-ゥム由来の高い殺菌力を有し、発泡性 能や味、使用感を損なわず、粘膜刺激もないこと、泡保持性、泡のきめ細かさが高い ことを確認した。 The above toothpaste composition has high bactericidal power derived from cetylpyridium salt, does not impair foaming performance, taste, and feeling of use, does not irritate mucous membranes, and has excellent foam retention and fine foam. I confirmed that it was high.
〔実施例 18〕練歯磨 [Example 18] Toothpaste
塩化セチルピリジ-ゥム 0. 05% Cetylpyridium chloride 0.05%
酢酸 dl—トコフエロール 0. 05 Acetic acid dl—tocopherol 0.05
ヒドロキシェチノレセノレロース 1. 0 Hydroxyethinoresenolose 1.0
ヒドロキシプロピルメチルセルロース 0. 4 Hydroxypropyl methylcellulose 0.4
ポリオキシエチレン(20)硬化ヒマシ油 0. 8 Polyoxyethylene (20) hydrogenated castor oil 0.8
2 -ヤシ油アルキル— N—カルボキシメチル - N—ヒドロキシェチノレイミダゾリ-ゥムベタインナトリウム(* 1) 0. 8 2-Coconut oil alkyl- N-carboxymethyl- N-hydroxyethynoleimidazolium betaine sodium (* 1) 0. 8
歯磨用リン酸水素カルシウム · 2水和物 40 Calcium hydrogen phosphate dihydrate for toothpaste 40
85%グリセリン 18 85% Glycerin 18
サッカリンナトリウム 0. 2 Saccharin sodium 0.2
ポリオキシエチレングリコール 400 3. 0 Polyoxyethylene glycol 400 3. 0
酸化チタン 0. 3 Titanium oxide 0.3
モノフルォロリン酸ナトリウム 0. 73 Sodium monofluorophosphate 0.73
香料 1. 0 Fragrance 1.0
2t 33. 67 2t 33.67
計 100.0% Total 100.0%
* 1:30%品を用い、純分換算した配合量を示した。 * 1:30% product is used, and the blended amount is shown in terms of pure content.
(C) / (B) : 0. 8 (C) / (B) : 0.8
(D) / (C) : 0. 4 (D) / (C) : 0.4
水分量: 36. 37質量% Moisture content: 36.37% by mass
上記の歯磨組成物は、塩ィ匕セチルピリジ-ゥム由来の高い殺菌力を有し、かつ、発 泡性能や味、使用感を損なわず、粘膜刺激もなぐ泡保持性、泡のきめ細かさが高
いことを確認した。 The above dentifrice composition has high bactericidal power derived from cetylpyridium salt, and also has good foam retention and fine foam that does not impair foaming performance, taste, or feeling of use, and does not cause mucous membrane irritation. high I confirmed that it was.
〔実施例 19〕練歯磨 [Example 19] Toothpaste
塩化セチルピリジ-ゥム 0. 05% Cetylpyridium chloride 0.05%
酢酸 dl—トコフエロール 0. 1 Acetic acid dl—tocopherol 0.1
ヒドロキシェチノレセノレロース 1. 0 Hydroxyethinoresenolose 1.0
ヒドロキシプロピノレメチノレセノレロース 0. 1 Hydroxypropynoremethinoresenolose 0.1
アルキルグリコシド 2. 0 Alkyl glycoside 2.0
ヤシ油脂肪酸アミドプロピルべタイン( * 1) 0. 1 Coconut oil fatty acid amidopropyl betaine (* 1) 0. 1
2 -ヤシ油アルキル— N—カルボキシメチル - N—ヒドロキシェチノレイミダゾリ-ゥムベタインナトリウム(* 2) 0. 3 2-Coconut oil alkyl- N-carboxymethyl- N-hydroxyethynoleimidazolium betaine sodium (* 2) 0. 3
歯磨用リン酸水素カルシウム · 2水和物 38 Calcium hydrogen phosphate dihydrate for toothpaste 38
70%ソノレビット液 15 70% Sonolevit liquid 15
80%グリセリン 4. 0 80% glycerin 4.0
サッカリンナトリウム 0. 2 Saccharin sodium 0.2
プロピレングリコール 3. 0 Propylene glycol 3.0
酸化チタン 0. 1 Titanium oxide 0.1
モノフルォロリン酸ナトリウム 0. 73 Sodium monofluorophosphate 0.73
香料 1. 0 Fragrance 1.0
Zt 34. 32 Zt 34. 32
計 100.0% Total 100.0%
* 1:30%品を用い、純分換算した配合量を示した。 * 1:30% product is used, and the blended amount is shown in terms of pure content.
* 2:30%品を用い、純分換算した配合量を示した。 * 2:30% product is used, and the blended amount is shown in terms of pure content.
(C) / (B) : 0. 4 (C) / (B) : 0. 4
(D) / (C) : 0. 1 (D) / (C) : 0. 1
水分量: 39. 62質量% Moisture content: 39.62% by mass
上記の歯磨組成物は、塩ィ匕セチルピリジニゥムの殺菌力を有し、発泡性能や味、使 用感を損なわず、粘膜刺激もないこと、泡保持性、泡のきめ細力さが高いことを確認 した。
The above toothpaste composition has the bactericidal power of cetylpyridinium salt, does not impair foaming performance, taste, and feeling of use, does not irritate mucous membranes, and has excellent foam retention and foam fineness. It was confirmed that the
Claims
[1] (A)塩化セチルピリジ-ゥム、 (B)ヒドロキシェチルセルロース、 (C)アルキルジメチ ルァミノ酢酸べタイン、脂肪酸アミドプロピルべタイン、 2—アルキル—N—カルボキシ メチル N ヒドロキシェチルイミダゾリ-ゥムベタインから選ばれる少なくとも 1種の 両性界面活性剤を含有し、前記 (B)成分に対する (C)成分の配合割合が質量比で 0. 06〜3であり、かつ組成物中の水分含量が 50質量%以下であり、ァニオン性界 面活性剤を実質的に含有しないことを特徴とする歯磨組成物。 [1] (A) Cetylpyridium chloride, (B) Hydroxyethyl cellulose, (C) Alkyl dimethylaminoacetic acid betaine, fatty acid amidopropyl betaine, 2-alkyl-N-carboxy methyl N-hydroxyethyl imidazolyte The composition contains at least one amphoteric surfactant selected from -umbetaine, the proportion of component (C) to component (B) is 0.06 to 3 by mass, and the water content in the composition is 0.06 to 3. A dentifrice composition characterized in that it contains no more than 50% by mass and substantially no anionic surfactant.
[2] 更に、(D)ヒドロキシプロピルメチルセルロースを含有し、(B)成分に対する(D)成 分の配合割合が質量比で 0. 06〜2. 5であることを特徴とする請求項 1記載の歯磨 組成物。 [2] Claim 1, further comprising (D) hydroxypropyl methylcellulose, and the blending ratio of component (D) to component (B) is 0.06 to 2.5 by mass. toothpaste composition.
[3] 更に、研磨剤を 7〜60質量%、粘稠剤を 5〜50質量%、及び粘結剤を 0. 1〜5質 量%配合し、練歯磨組成物として調製された請求項 1又は 2記載の歯磨組成物。
[3] A claim in which the toothpaste composition is prepared by further blending 7 to 60% by mass of an abrasive, 5 to 50% by mass of a thickening agent, and 0.1 to 5% by mass of a binding agent. The dentifrice composition according to 1 or 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007549057A JPWO2007066497A1 (en) | 2005-12-09 | 2006-11-20 | Dentifrice composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-356116 | 2005-12-09 | ||
JP2005356116 | 2005-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007066497A1 true WO2007066497A1 (en) | 2007-06-14 |
Family
ID=38122646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/323076 WO2007066497A1 (en) | 2005-12-09 | 2006-11-20 | Dentifrice composition |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2007066497A1 (en) |
WO (1) | WO2007066497A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010143868A (en) * | 2008-12-19 | 2010-07-01 | Wakamoto Pharmaceut Co Ltd | Cosmetic product |
JP5039243B2 (en) * | 2010-09-24 | 2012-10-03 | 大同化成工業株式会社 | Foam type external preparation for skin |
WO2012132747A1 (en) * | 2011-03-25 | 2012-10-04 | ライオン株式会社 | Liquid composition for oral cavity and method for stable addition of components to composition |
JP2013155166A (en) * | 2012-02-01 | 2013-08-15 | Lion Corp | Dentifrice composition |
JP2014210743A (en) * | 2013-04-19 | 2014-11-13 | アース製薬株式会社 | Liquid oral composition |
WO2015097899A1 (en) * | 2013-12-27 | 2015-07-02 | 花王株式会社 | Oral composition |
JP2017078029A (en) * | 2015-10-19 | 2017-04-27 | アース製薬株式会社 | Sterilization method and sterilization composition |
JP2018043982A (en) * | 2016-09-07 | 2018-03-22 | 第一三共ヘルスケア株式会社 | Oral composition containing cationic fungicide, unmodified silica, and betaine surfactant |
WO2020016926A1 (en) * | 2018-07-17 | 2020-01-23 | 日本ゼトック株式会社 | Nonaqueous composition for oral cavity |
JP2020083787A (en) * | 2018-11-19 | 2020-06-04 | サンスター株式会社 | Composition for oral cavity |
JP2021147318A (en) * | 2020-03-16 | 2021-09-27 | サンスター株式会社 | Oral composition |
JP2021147317A (en) * | 2020-03-16 | 2021-09-27 | サンスター株式会社 | Oral composition |
US12083209B2 (en) | 2020-02-18 | 2024-09-10 | Sunstar Americas, Inc. | Oral care composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05931A (en) * | 1991-06-25 | 1993-01-08 | Lion Corp | Composition for oral cavity |
JPH0624947A (en) * | 1992-07-06 | 1994-02-01 | Sunstar Inc | Composition for oral cavity |
JP2002179541A (en) * | 2000-12-08 | 2002-06-26 | Sunstar Inc | Composition for oral cavity containing cationic disinfectant |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3814142B2 (en) * | 2000-12-08 | 2006-08-23 | サンスター株式会社 | Oral composition |
-
2006
- 2006-11-20 JP JP2007549057A patent/JPWO2007066497A1/en active Pending
- 2006-11-20 WO PCT/JP2006/323076 patent/WO2007066497A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05931A (en) * | 1991-06-25 | 1993-01-08 | Lion Corp | Composition for oral cavity |
JPH0624947A (en) * | 1992-07-06 | 1994-02-01 | Sunstar Inc | Composition for oral cavity |
JP2002179541A (en) * | 2000-12-08 | 2002-06-26 | Sunstar Inc | Composition for oral cavity containing cationic disinfectant |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010143868A (en) * | 2008-12-19 | 2010-07-01 | Wakamoto Pharmaceut Co Ltd | Cosmetic product |
JP5039243B2 (en) * | 2010-09-24 | 2012-10-03 | 大同化成工業株式会社 | Foam type external preparation for skin |
JP2012211180A (en) * | 2010-09-24 | 2012-11-01 | Daido Kasei Kogyo Kk | Foam-type external skin preparation |
WO2012132747A1 (en) * | 2011-03-25 | 2012-10-04 | ライオン株式会社 | Liquid composition for oral cavity and method for stable addition of components to composition |
JP2012201632A (en) * | 2011-03-25 | 2012-10-22 | Lion Corp | Liquid composition for oral cavity and method for stable addition of component to the composition |
CN103458864A (en) * | 2011-03-25 | 2013-12-18 | 狮王株式会社 | Liquid composition for oral cavity and method for stable addition of components to composition |
JP2013155166A (en) * | 2012-02-01 | 2013-08-15 | Lion Corp | Dentifrice composition |
JP2014210743A (en) * | 2013-04-19 | 2014-11-13 | アース製薬株式会社 | Liquid oral composition |
US10307358B2 (en) | 2013-12-27 | 2019-06-04 | Kao Corporation | Oral composition |
WO2015097899A1 (en) * | 2013-12-27 | 2015-07-02 | 花王株式会社 | Oral composition |
JP2017078029A (en) * | 2015-10-19 | 2017-04-27 | アース製薬株式会社 | Sterilization method and sterilization composition |
JP2018043982A (en) * | 2016-09-07 | 2018-03-22 | 第一三共ヘルスケア株式会社 | Oral composition containing cationic fungicide, unmodified silica, and betaine surfactant |
JP7032889B2 (en) | 2016-09-07 | 2022-03-09 | 第一三共ヘルスケア株式会社 | Oral composition comprising a cationic fungicide, unmodified silica, and a betaine-based surfactant. |
WO2020016926A1 (en) * | 2018-07-17 | 2020-01-23 | 日本ゼトック株式会社 | Nonaqueous composition for oral cavity |
CN112041030A (en) * | 2018-07-17 | 2020-12-04 | 日本泽托克株式会社 | Non-aqueous oral care compositions |
CN112041030B (en) * | 2018-07-17 | 2023-08-15 | 日本泽托克株式会社 | Nonaqueous oral care compositions |
JP2020083787A (en) * | 2018-11-19 | 2020-06-04 | サンスター株式会社 | Composition for oral cavity |
US12083209B2 (en) | 2020-02-18 | 2024-09-10 | Sunstar Americas, Inc. | Oral care composition |
JP2021147318A (en) * | 2020-03-16 | 2021-09-27 | サンスター株式会社 | Oral composition |
JP2021147317A (en) * | 2020-03-16 | 2021-09-27 | サンスター株式会社 | Oral composition |
JP7467173B2 (en) | 2020-03-16 | 2024-04-15 | サンスター株式会社 | Oral Composition |
JP7467172B2 (en) | 2020-03-16 | 2024-04-15 | サンスター株式会社 | Oral Composition |
Also Published As
Publication number | Publication date |
---|---|
JPWO2007066497A1 (en) | 2009-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007066497A1 (en) | Dentifrice composition | |
JP7251998B2 (en) | Liquid oral composition | |
JP5625647B2 (en) | Dentifrice composition | |
JP6318487B2 (en) | Oral composition | |
JP5597969B2 (en) | Dentifrice composition | |
JP5381685B2 (en) | Dentifrice composition | |
JPWO2018194111A1 (en) | Oral biofilm remover and oral composition | |
CN106999363B (en) | Oral composition | |
JP5310556B2 (en) | Oral composition and method for improving astringency of oral composition | |
JP2020011951A (en) | Oral composition | |
JP2006182662A (en) | Dentifrice composition | |
JP2013067567A (en) | Dentifrice composition | |
JP2011126819A (en) | Composition for oral cavity | |
JP2015117215A (en) | Dentifrice composition | |
JP3894132B2 (en) | Dentifrice composition | |
JP2007145740A (en) | Dentifrice composition | |
JP5228380B2 (en) | Dentifrice composition | |
JP4158036B2 (en) | Dentifrice composition and method for producing the same | |
JP5227089B2 (en) | Oral composition | |
JP2009137897A (en) | Dentifrice composition | |
JP2006347987A (en) | Composition for oral cavity and method for enhancing foamability of composition for oral cavity | |
JP2005041787A (en) | Dentifrice composition | |
JP2010143842A (en) | Dentifrice composition | |
JP7172028B2 (en) | oral composition | |
JP7670063B2 (en) | Polyhydric alcohol-based dentifrice composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007549057 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06832937 Country of ref document: EP Kind code of ref document: A1 |